Document:

<PAGE>

                                                                    Exhibit 10.7

                                TOWER GROUP, INC.
                     2004 LONG TERM EQUITY COMPENSATION PLAN

                                 August 26, 2004

<PAGE>

<TABLE>
<S>                                                                                                           <C>
Contents
-------------------------------------------------------------------------------------------------------------------

                                                                                                              PAGE

Article 1.     Establishment, Objectives, and Duration............................................................1

Article 2.     Definitions........................................................................................1

Article 3.     Administration.....................................................................................5

Article 4.     Shares Subject to the Plan; Individual Limits; and Anti-Dilution Adjustment........................5

Article 5.     Eligibility and Participation......................................................................6

Article 6.     Options............................................................................................7

Article 7.     Stock Appreciation Rights..........................................................................8

Article 8.     Restricted Stock..................................................................................10

Article 9.     Restricted Stock Units and Performance Shares.....................................................11

Article 10.    Other Awards......................................................................................13

Article 11.    Performance Measures..............................................................................13

Article 12.    Beneficiary Designation...........................................................................13

Article 13.    Deferrals.........................................................................................14

Article 14.    Rights of Participants............................................................................14

Article 15.    Change in Control.................................................................................14

Article 16.    Amendment, Modification, and Termination..........................................................15

Article 17.    Withholding.......................................................................................15

Article 18.    Indemnification...................................................................................16

Article 19.    Successors........................................................................................16

Article 20.    Legal Construction................................................................................16
</TABLE>

<PAGE>

                                TOWER GROUP, INC.
                     2004 LONG TERM EQUITY COMPENSATION PLAN

ARTICLE 1.        ESTABLISHMENT, OBJECTIVES, AND DURATION

         1.1. ESTABLISHMENT OF THE PLAN. Tower Group, Inc., a Delaware
corporation (the "Company"), hereby establishes an incentive compensation plan
to be known as the "Tower Group, Inc. 2004 Long Term Equity Compensation Plan"
(the "Plan"), as set forth in this document and individual Award Agreements
setting forth certain terms and conditions applicable to Awards. The Plan
permits the granting of Nonqualified Stock Options, Incentive Stock Options,
Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance
Shares and other awards.

         The Plan shall become effective August 26, 2004 (the "Effective Date"),
subject to shareholder approval, and shall remain in effect as provided in
Section 1.3 herein.

         1.2. OBJECTIVES OF THE PLAN. The objectives of the Plan are to optimize
the profitability and growth of the Company through incentives which are
consistent with the Company's goals and which link the personal interests of
Participants to those of the Company's shareholders.

         The Plan is further intended to provide flexibility to the Company in
its ability to motivate, attract, and retain the services of Participants who
make or are expected to make significant contributions to the Company's success
and to allow Participants to share in the success of the Company.

         1.3. DURATION OF THE PLAN. The Plan shall commence on the Effective
Date, as described in Section 1.1 herein, and shall remain in effect, subject to
the right of the Board to amend or terminate the Plan in accordance with the
provisions of Article 16 herein, until all Shares subject to it shall have been
purchased or acquired according to the Plan's provisions. However, in no event
may an Incentive Stock Option be granted under the Plan on or after the tenth
anniversary of the Effective Date.

ARTICLE 2.        DEFINITIONS

         The following terms, when capitalized, shall have the meanings set
forth below:

         2.1. "AWARD" means, individually or collectively, Nonqualified Stock
Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock,
Restricted Stock Units, Performance Shares and other awards granted under the
Plan.

         2.2. "AWARD AGREEMENT" means an agreement entered into by the Company
and a Participant setting forth the terms and provisions applicable to an Award.

         2.3. "BOARD" means the Board of Directors of the Company.

<PAGE>

         2.4. "CHANGE IN CONTROL" means the occurrence of any of the following
events:

                  (A) any Person (other than the Company, any trustee or other
                      fiduciary holding securities under an employee benefit
                      plan of the Company, or any corporation owned directly or
                      indirectly by the stockholders of the Company in
                      substantially the same proportion as the ownership of
                      stock of the Company) that is not on the Effective Date
                      the "beneficial owner" (as defined in Rule 13d-3 under the
                      Exchange Act), directly or indirectly, of securities of
                      the Company representing more than 20% of the combined
                      voting power of the Company's then outstanding securities
                      becomes after the Effective Date the beneficial owner,
                      directly or indirectly, of securities of the Company
                      representing more than 20% of the combined voting power of
                      the Company's then outstanding securities;

                  (B) individuals who, as of the Effective Date, constitute the
                      Board (the "Incumbent Board") cease for any reason to
                      constitute at least a majority of the Board of the
                      Company, provided that any person becoming a director
                      subsequent to the date hereof whose election, or
                      nomination for election by the Company's stockholders, was
                      approved by a vote of at least a majority of the directors
                      then comprising the Incumbent Board (other than an
                      election or nomination of an individual whose initial
                      assumption of office is in connection with an actual or
                      threatened election contest relating to the election of
                      the directors of the Company) shall be, for purposes of
                      this definition, considered as though such person were a
                      member of the Incumbent Board;

                  (C) consummation of a merger, consolidation, reorganization,
                      share exchange or similar transaction (a "Transaction") of
                      the Company with any other entity, other than (i) a
                      Transaction that would result in the voting securities of
                      the Company outstanding immediately prior thereto directly
                      or indirectly continuing to represent (either by remaining
                      outstanding or by being converted into voting securities
                      of the surviving entity or a parent company) more than 80%
                      of the combined voting power of the voting securities of
                      the Company or such surviving entity or parent company
                      outstanding immediately after such Transaction or (ii) a
                      Transaction effected to implement a recapitalization of
                      the Company (or similar transaction) in which no Person
                      acquires more than 20% of the combined voting power of the
                      Company's then outstanding securities;

                  (D) the sale, transfer or other disposition (in one
                      transaction or a series of related transactions) of more
                      than 50% of the operating assets of the Company; or

                  (E) the approval by the shareholders of a plan or proposal for
                      the liquidation or dissolution of the Company.

                                       2
<PAGE>

         Notwithstanding anything to the contrary contained herein, an initial
public offering of the Company's Shares shall not constitute a Change in Control
for purposes of this Plan.

         2.5. "CODE" means the Internal Revenue Code of 1986, as amended from
time to time.

         2.6. "COMMITTEE" means the Committee, as specified in Section 3.1
herein, appointed by the Board to administer the Plan.

         2.7. "COMPANY" means Tower Group, Inc., a Delaware corporation, and any
successor thereto as provided in Article 19 herein.

         2.8. "CONSULTANT" means any consultant or advisor to the Company or a
Subsidiary.

         2.9. "DIRECTOR" means any individual who is a member of the Board of
Directors of the Company or a Subsidiary.

         2.10. "DIVIDEND EQUIVALENT" means, with respect to Shares subject to an
Award, a right to be paid an amount equal to the dividends declared on an equal
number of outstanding Shares.

         2.11. "EFFECTIVE DATE" shall have the meaning ascribed to such term in
Section 1.1 herein.

         2.12. "EMPLOYEE" means any employee of the Company or a Subsidiary.

         2.13. "EXCHANGE ACT" means the Securities Exchange Act of 1934, as
amended from time to time.

         2.14. "EXERCISE PRICE" means the price at which a Share may be
purchased by a Participant pursuant to an Option.

         2.15. "FAIR MARKET VALUE" means the average of the high and low sale
prices of a Share as reported in the consolidated transaction reporting system,
or, if there was no such sale on the relevant date, then on the last previous
day on which a sale was reported.

         2.16. "FREESTANDING SAR" means an SAR that is granted independently of
any Options, as described in Article 7 herein.

         2.17. "INCENTIVE STOCK OPTION" or "ISO" means an Option that is
intended to meet the requirements of Code Section 422.

         2.18. "NAMED EXECUTIVE OFFICER" means a Participant who is one of the
group of "covered employees," as defined in the regulations promulgated under
Code Section 162(m).

         2.19. "NONQUALIFIED STOCK OPTION" or "NQSO" means an Option to purchase
Shares granted under Article 6 herein and that is not intended to meet the
requirements of Code Section 422.

                                       3
<PAGE>

         2.20. "OPTION" means an Incentive Stock Option or a Nonqualified Stock
Option, as described in Article 6 herein.

         2.21. "PARTICIPANT" means a current or former Employee, Director or
Consultant who has outstanding an Award granted under the Plan.

         2.22. "PERFORMANCE-BASED EXCEPTION" means the performance-based
exception from the tax deductibility limitations of Code Section 162(m).

         2.23. "PERFORMANCE PERIOD" means the period during which a performance
goal must be met.

         2.24. "PERFORMANCE SHARE" means an Award granted to a Participant, as
described in Article 9 herein.

         2.25. "PERIOD OF RESTRICTION" means the period during which Restricted
Stock or Restricted Share Units are subject to a substantial risk of forfeiture
(based on the passage of time, the achievement of performance measures, or upon
the occurrence of other events as determined by the Committee, at its
discretion), as provided in Articles 8 and 9 herein.

         2.26. "PERSON" shall have the meaning ascribed to such term in Section
3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof,
including a "group" as defined in Section 13(d) thereof.

         2.27. "RESTRICTED STOCK" means an Award granted to a Participant, as
described in Article 8 herein.

         2.28. "RESTRICTED STOCK UNIT" means an Award granted to a Participant,
as described in Article 9 herein.

         2.29. "SHARE" means a share of common stock of the Company, par value
$0.01 per share, subject to adjustment pursuant to Section 4.3 herein.

         2.30. "STOCK APPRECIATION RIGHT" or "SAR" means an Award granted to a
Participant, either alone or in connection with a related Option, as described
in Article 7 herein.

         2.31. "SUBSIDIARY" means any corporation (other than the Company) in an
unbroken chain of corporations beginning with the Company if each of the
corporations other than the last corporation in the chain owns stock possessing
fifty percent or more of the total combined voting power of all classes of stock
in one of the other corporations in such chain.

         2.32. "TANDEM SAR" means an SAR that is granted in connection with a
related Option, as described in Article 7 herein.

         2.33. "TEN PERCENT SHAREHOLDER" means, with respect to an ISO, a
Participant who, at the time the ISO is granted, owns stock possessing more than
ten percent (10%) of the total combined voting power of all classes of stock of
the Company or of any parent corporation (as that term is defined in Code
Section 424(e)) or Subsidiary.

                                       4
<PAGE>

ARTICLE 3.        ADMINISTRATION

         3.1. THE COMMITTEE. The Plan shall be administered by the Compensation
Committee of the Board or such other committee (the "Committee") as the Board
shall select consisting solely of two or more members of the Board. The members
of the Committee shall be appointed from time to time by, and shall serve at the
discretion of, the Board of Directors.

         3.2. AUTHORITY OF THE COMMITTEE. Except as limited by law or by the
Company's Certificate of Incorporation or Bylaws (as the same may be amended
and/or restated from time to time), and subject to the provisions herein, the
Committee shall have full power to select the Employees, Directors and
Consultants who shall participate in the Plan; determine the sizes and types of
Awards; determine the terms and conditions of Awards in a manner consistent with
the Plan; construe and interpret the Plan and any Award Agreement or other
agreement or instrument entered into under the Plan; establish, amend, or waive
rules and regulations for the Plan's administration; and (subject to the
provisions of Sections 16.3 herein) amend the terms and conditions of any
outstanding Award. Further, the Committee shall make all other determinations
which may be necessary or advisable for the administration of the Plan. As
permitted by law, the Committee may delegate its authority as identified herein.

         3.3. DECISIONS BINDING. All determinations and decisions made by the
Committee pursuant to the provisions of the Plan and all related orders and
resolutions of the Board shall be final, conclusive and binding on all persons,
including the Company, its Subsidiaries, its shareholders, Directors, Employees,
Consultants and their estates and beneficiaries.

ARTICLE 4.        SHARES SUBJECT TO THE PLAN; INDIVIDUAL LIMITS; AND
                  ANTI-DILUTION ADJUSTMENT

         4.1. SHARES AVAILABLE FOR GRANTS.

                  (A) Subject to adjustment as provided in Section 4.3 herein,
                      the maximum number of Shares that may be delivered
                      pursuant to Awards under the Plan shall be 645,957. This
                      maximum number of Shares includes Shares that were
                      available for awards under the Tower Group, Inc. 2001
                      Stock Award Plan, but which were not (and may no longer
                      be) made subject to awards under such plans.

                  (B) Subject to adjustment as provided in Section 4.3 herein,
                      the aggregate number of Shares that may be delivered
                      pursuant to Awards of Restricted Stock, Restricted Stock
                      Units, Performance Shares and other awards may be granted
                      under the Plan may not exceed 484,468 Shares.

                  (C) If an Award is not settled in Shares or is forfeited,
                      expires or is canceled without delivery of Shares, the
                      Shares subject to such Award shall again be available for
                      delivery under the Plan. Shares granted pursuant to the
                      Plan may be authorized but unissued Shares, treasury
                      Shares or Shares purchased on the open market.

                                       5
<PAGE>

         4.2. INDIVIDUAL LIMITS. Subject to adjustment as provided in Section
4.3 herein, the following rules shall apply with respect to Awards and any
related dividends or Dividend Equivalents intended to qualify for the
Performance-Based Exception:

                  (A) OPTIONS: The maximum aggregate number of Shares with
                      respect to which Options may be granted in any one fiscal
                      year to any one Participant shall be 277,778.

                  (B) SARS: The maximum aggregate number of Shares with respect
                      to which Stock Appreciation Rights may be granted in any
                      one fiscal year to any one Participant shall be
                      277,778.

                  (C) RESTRICTED STOCK: The maximum aggregate number of Shares
                      of Restricted Stock that may be granted in any one fiscal
                      year to any one Participant shall be 138,889.

                  (D) RESTRICTED STOCK UNITS. The maximum aggregate number of
                      Restricted Stock Units that may be granted in any one
                      fiscal year to any one Participant shall be 138,889.

                  (E) PERFORMANCE SHARES: The maximum aggregate number of
                      Performance Shares that may be granted in any one fiscal
                      year to any one Participant shall be 138,889.

                  (F) OTHER AWARDS. The maximum number of Shares that may be
                      awarded in any one year to any one Participant pursuant to
                      an Award under Article 10 shall be 138,889 Shares and
                      the maximum cash Award that may be awarded in any one year
                      to any one Participant pursuant to an Award under Article
                      10 shall be $5,000,000.

                  (G) DIVIDENDS AND DIVIDEND EQUIVALENTS: The maximum dividend
                      or Dividend Equivalents that may be paid in any one fiscal
                      year to any one Participant shall be $300,000.

         4.3. ADJUSTMENTS IN AUTHORIZED SHARES. In the event of any merger,
reorganization, consolidation, recapitalization, liquidation, stock dividend,
split-up, spin-off, stock split, reverse stock split, share combination, share
exchange or other change in the corporate structure of the Company affecting the
Shares, such adjustment shall be made in the number and kind of Shares that may
be delivered under the Plan, the individual limits set forth in Section 4.2
herein, and in the number and kind of and/or price of Shares subject to
outstanding Awards, as may be determined to be appropriate and equitable by the
Committee, in its sole discretion, to prevent dilution or enlargement of rights;
provided, however, that the number of Shares subject to an Award shall always be
rounded down to a whole number.

ARTICLE 5.        ELIGIBILITY AND PARTICIPATION

         5.1. ELIGIBILITY. Persons eligible to participate in the Plan include
all Employees, Directors and Consultants.

                                       6
<PAGE>

         5.2. ACTUAL PARTICIPATION. Subject to the provisions of the Plan, the
Committee may, from time to time, select from all eligible Employees, Directors
and Consultants, those to whom Awards shall be granted and shall determine the
nature and amount of each Award.

ARTICLE 6.        OPTIONS

         6.1. GRANT OF OPTIONS. Subject to the terms and provisions of the Plan,
Options may be granted to Participants in such number, and upon such terms, and
at any time and from time to time, as shall be determined by the Committee.

         6.2. AWARD AGREEMENT. Each Option grant shall be evidenced by an Award
Agreement that shall specify the Exercise Price, the duration of the Option, the
number of Shares to which the Option pertains, and such other provisions as the
Committee shall determine. The Award Agreement also shall specify whether the
Option is intended to be an ISO or an NQSO.

         6.3. EXERCISE PRICE. The Exercise Price for each grant of an Option
under the Plan shall be at least equal to one hundred percent (100%) of the Fair
Market Value of a Share on the date the Option is granted. The Exercise Price of
an ISO granted to a Ten Percent Shareholder shall be at least equal to one
hundred and ten percent (110%) of the Fair Market Value of a Share on the date
the ISO is granted.

         6.4. DURATION OF OPTIONS. Each Option granted to a Participant shall
expire at such time as the Committee shall determine at the time of grant;
provided, however, that no Option shall be exercisable later than the tenth
(10th) anniversary date of its grant and no ISO granted to a Ten Percent
Shareholder shall be exercisable later than the fifth (5th) anniversary date of
its grant.

         6.5. EXERCISE OF OPTIONS. Options granted under this Article 6 shall be
exercisable at such times and be subject to such restrictions and conditions as
set forth in the Award Agreement and as the Committee shall in each instance
approve, which need not be the same for each grant or for each Participant.
Options which are intended to be ISOs shall be subject to the $100,000 annual
vesting limitation set forth in Code Section 422(d).

         6.6. PAYMENT. Options granted under this Article 6 shall be exercised
by the delivery of a written notice of exercise to the Company, setting forth
the number of Shares with respect to which the Option is to be exercised,
accompanied by provisions for full payment for the Shares.

         The Exercise Price of an Option shall be payable as follows, in each
case subject to such restrictions as the Committee may impose: (a) in cash or
its equivalent, (b) by tendering, or attesting to the ownership of, previously
acquired Shares having an aggregate Fair Market Value at the time of exercise
equal to the total Exercise Price (provided that the Shares, other than Shares
purchased by the Participant on the open market, which are tendered must have
been held by the Participant for at least six (6) months prior to their tender
to satisfy the Exercise Price), (c) by broker-assisted cashless exercise, (d) by
any other method approved by the Committee or (e) by a combination of (a), (b),
(c) and/or (d). The Committee may limit any method of payment, other than that
specified under (a), for administrative convenience, to comply with applicable
law, or for any other reason.

                                       7
<PAGE>

         Subject to any governing rules or regulations, as soon as practicable
after receipt of a written notification of exercise and full payment, the
Company shall deliver or cause to be delivered Shares in an appropriate amount
based upon the number of Shares purchased under the Option(s).

         6.7. RESTRICTIONS ON SHARE TRANSFERABILITY. The Committee may impose
such restrictions on any Shares acquired pursuant to the exercise of an Option
granted under this Article 6 as it may deem advisable, including, without
limitation, restrictions under applicable federal securities laws, under the
requirements of any stock exchange or market upon which such Shares are then
listed and/or traded, and under any blue sky or state securities laws applicable
to such Shares.

         6.8. DIVIDEND EQUIVALENTS. At the discretion of the Committee, an Award
of Options may provide the Participant with the right to receive Dividend
Equivalents, which may be paid currently or credited to an account for the
Participant, and may be settled in cash and/or Shares, as determined by the
Committee in its sole discretion, subject in each case to such terms and
conditions as the Committee shall establish. Without limiting the generality of
the preceding sentence, if it is intended that an Award of Options and/or the
Dividend Equivalents comply with the requirements of the Performance-Based
Exception, the Committee may apply any restrictions it deems appropriate to the
payment of Dividend Equivalents awarded with respect to such Options, such that
the Options and/or Dividend Equivalents maintain eligibility for the
Performance-Based Exception.

         6.9. TERMINATION OF EMPLOYMENT OR SERVICE. Each Participant's Option
Award Agreement shall set forth the extent to which the Participant shall have
the right to exercise the Option following termination of the Participant's
employment or, if the Participant is a Director or Consultant, service with the
Company and its Subsidiaries. Such provisions shall be determined in the sole
discretion of the Committee, need not be uniform among all Options, and may
reflect distinctions based on the reasons for termination of employment or
service.

         6.10. NONTRANSFERABILITY OF OPTIONS.

                  (A) INCENTIVE STOCK OPTIONS. ISOs may not be sold,
                      transferred, pledged, assigned, or otherwise alienated or
                      hypothecated, other than by will or by the laws of descent
                      and distribution, and shall be exercisable during a
                      Participant's lifetime only by such Participant.

                  (B) NONQUALIFIED STOCK OPTIONS. Except as otherwise provided
                      in a Participant's Award Agreement, NQSOs may not be sold,
                      transferred, pledged, assigned, or otherwise alienated or
                      hypothecated, other than by will or by the laws of descent
                      and distribution, and shall be exercisable during a
                      Participant's lifetime only by such Participant.

ARTICLE 7.        STOCK APPRECIATION RIGHTS

         7.1. GRANT OF SARS. Subject to the terms and provisions of the Plan,
SARs may be granted to Participants at any time and from time to time as shall
be determined by the Committee. The Committee may grant Freestanding SARs,
Tandem SARs, or any combination of these forms of SAR.

                                       8
<PAGE>

         The Committee shall have complete discretion in determining the number
of SARs granted to each Participant (subject to Article 4 herein) and,
consistent with the provisions of the Plan, in determining the terms and
conditions pertaining to such SARs.

         The grant price of a Freestanding SAR shall equal the Fair Market Value
of a Share on the date of grant of the SAR. The grant price of a Tandem SAR
shall equal the Exercise Price of the related Option.

         7.2. EXERCISE OF TANDEM SARS. A Tandem SAR may be exercised only with
respect to the Shares for which its related Option is then exercisable. To the
extent exercisable, Tandem SARs may be exercised for all or part of the Shares
subject to the related Option. The exercise of all or part of a Tandem SAR shall
result in the forfeiture of the right to purchase a number of Shares under the
related Option equal to the number of Shares with respect to which the SAR is
exercised. Conversely, upon exercise of all or part of an Option with respect to
which a Tandem SAR has been granted, an equivalent portion of the Tandem SAR
shall similarly be forfeited.

         Notwithstanding any other provision of the Plan to the contrary, with
respect to a Tandem SAR granted in connection with an ISO: (i) the Tandem SAR
will expire no later than the expiration of the underlying ISO; (ii) the value
of the payout with respect to the Tandem SAR may be for no more than one hundred
percent (100%) of the difference between the Exercise Price of the underlying
ISO and the Fair Market Value of the Shares subject to the underlying ISO at the
time the Tandem SAR is exercised; and (iii) the Tandem SAR may be exercised only
when the Fair Market Value of the Shares subject to the ISO exceeds the Exercise
Price of the ISO.

         7.3. EXERCISE OF FREESTANDING SARS. Freestanding SARs may be exercised
upon whatever terms and conditions the Committee, in its sole discretion,
imposes upon them and sets forth in the Award Agreement.

         7.4. AWARD AGREEMENT. Each SAR grant shall be evidenced by an Award
Agreement that shall specify the grant price, the term of the SAR, and such
other provisions as the Committee shall determine.

         7.5. TERM OF SARS. The term of an SAR granted under the Plan shall be
determined by the Committee, in its sole discretion; provided, however, that
such term shall not exceed ten (10) years.

         7.6. PAYMENT OF SAR AMOUNT. Upon exercise of an SAR, a Participant
shall be entitled to receive payment from the Company in an amount determined by
multiplying:

                  (A) the difference between the Fair Market Value of a Share on
                      the date of exercise over the grant price; by

                  (B) the number of Shares with respect to which the SAR is
                      exercised.

                                       9
<PAGE>

         At the discretion of the Committee, the payment upon SAR exercise may
be in cash, in Shares of equivalent value, or in some combination thereof.

         7.7. DIVIDEND EQUIVALENTS. At the discretion of the Committee, an Award
of SARs may provide the Participant with the right to receive Dividend
Equivalents, which may be paid currently or credited to an account for the
Participant, and may be settled in cash and/or Shares, as determined by the
Committee in its sole discretion, subject in each case to such terms and
conditions as the Committee shall establish. Without limiting the generality of
the preceding sentence, if it is intended that an Award of SARs and/or the
Dividend Equivalents comply with the requirements of the Performance-Based
Exception, the Committee may apply any restrictions it deems appropriate to the
payment of Dividend Equivalents awarded with respect to such SARs, such that the
SARs and/or Dividend Equivalents maintain eligibility for the Performance-Based
Exception. 7.8. TERMINATION OF EMPLOYMENT OR SERVICE. Each SAR Award Agreement
shall set forth the extent to which the Participant shall have the right to
exercise the SAR following termination of the Participant's employment or, if
the Participant is a Director or Consultant, service with the Company and its
Subsidiaries. Such provisions shall be determined in the sole discretion of the
Committee, need not be uniform among all SARs, and may reflect distinctions
based on the reasons for termination of employment or service.

         7.9. NONTRANSFERABILITY OF SARS. Except as otherwise provided in a
Participant's Award Agreement, SARs may not be sold, transferred, pledged,
assigned, or otherwise alienated or hypothecated, other than by will or by the
laws of descent and distribution, and shall be exercisable during a
Participant's lifetime only by such Participant.

ARTICLE 8.        RESTRICTED STOCK

         8.1. GRANT OF RESTRICTED STOCK. Subject to the terms and provisions of
the Plan, Restricted Stock may be granted to Participants in such amounts as the
Committee shall determine.

         8.2. AWARD AGREEMENT. Each Restricted Stock grant shall be evidenced by
an Award Agreement that shall specify the Period(s) of Restriction, the number
of Shares of Restricted Stock granted, and such other provisions as the
Committee shall determine.

         8.3. OTHER RESTRICTIONS. The Committee shall impose such other
conditions and/or restrictions on any Shares of Restricted Stock granted
pursuant to the Plan as it may deem advisable including, without limitation, a
requirement that Participants pay a stipulated purchase price for each Share of
Restricted Stock, restrictions based upon the achievement of specific
performance goals, time-based restrictions on vesting following the attainment
of the performance goals, time-based restrictions, and/or restrictions under
applicable laws or under the requirements of any stock exchange or market upon
which such Shares are listed or traded, or holding requirements or sale
restrictions placed on the Shares by the Company upon vesting of such Restricted
Stock.

                                       10
<PAGE>

         8.4. REMOVAL OF RESTRICTIONS. Restricted Stock shall become freely
transferable by the Participant after the last day of the Period of Restriction
applicable thereto. Once Restricted Stock is released from the restrictions, the
Participant shall be entitled to receive a certificate.

         8.5. VOTING RIGHTS. Unless otherwise determined by the Committee and
set forth in a Participant's Award Agreement, to the extent permitted or
required by law, as determined by the Committee, Participants holding Shares of
Restricted Stock granted hereunder may be granted the right to exercise full
voting rights with respect to those Shares during the Period of Restriction.

         8.6. DIVIDENDS AND OTHER DISTRIBUTIONS. Except as otherwise provided in
a Participant's Award Agreement, during the Period of Restriction, Participants
holding Shares of Restricted Stock shall receive all regular cash dividends paid
with respect to all Shares while they are so held, and all other distributions
paid with respect to such Restricted Stock shall be credited to Participants
subject to the same restrictions on transferability and forfeitability as the
Restricted Stock with respect to which they were paid and shall be paid at such
time following full vesting as are paid the Shares of Restricted Stock with
respect to which such distributions were made. Without limiting the generality
of the preceding sentence, if it is intended that an Award of Restricted Stock
and/or dividends comply with the requirements of the Performance-Based
Exception, the Committee may apply any restrictions it deems appropriate to the
payment of dividends declared with respect to such Restricted Stock, such that
the Restricted Stock and/or the dividends maintain eligibility for the
Performance-Based Exception.

         8.7. TERMINATION OF EMPLOYMENT OR SERVICE. Each Award Agreement shall
set forth the extent to which the Participant shall have the right to receive
unvested Restricted Stock following termination of the Participant's employment
or, if the Participant is a Director or Consultant, service with the Company and
its Subsidiaries. Such provisions shall be determined in the sole discretion of
the Committee, need not be uniform among all Awards of Restricted Stock, and may
reflect distinctions based on the reasons for termination of employment or
service.

         8.8. NONTRANSFERABILITY OF RESTRICTED STOCK. Except as otherwise
determined by the Committee, during the applicable Period of Restriction, a
Participant's rights with respect to the Restricted Stock granted under the Plan
shall be available during the Participant's lifetime only to such Participant,
and Restricted Stock may not be sold, transferred, pledged, assigned, or
otherwise alienated or hypothecated other than by will or by the laws of descent
and distribution.

ARTICLE 9.        RESTRICTED STOCK UNITS AND PERFORMANCE SHARES

         9.1. GRANT OF RESTRICTED STOCK UNITS/PERFORMANCE SHARES. Subject to the
terms and provisions of the Plan, Restricted Stock Units and Performance Shares
may be granted to Participants in such amounts and upon such terms, and at any
time and from time to time, as shall be determined by the Committee and as shall
be set forth in the Award Agreement.

         9.2. AWARD AGREEMENT. Each grant of Restricted Stock Units or
Performance Shares shall be evidenced by an Award Agreement that shall specify
the applicable Period(s) of Restriction or Performance Period(s) (as the case
may be), the number of Restricted Stock Units or Performance Shares granted, and
such other provisions as the Committee shall determine. The initial value of a
Restricted Stock Unit or Performance Share shall equal the Fair Market Value of
a Share on the date of grant.

                                       11
<PAGE>

         9.3. FORM AND TIMING OF PAYMENT.

                  (A) Except as otherwise provided in a Participant's Award
                      Agreement, payment of Restricted Stock Units shall be made
                      after the last day of the Period of Restriction applicable
                      thereto. The Committee, in its sole discretion, may pay
                      Restricted Stock Units in cash or in Shares (or in a
                      combination thereof) that have an aggregate Fair Market
                      Value equal to the value of the earned Restricted Stock
                      Units.

                  (B) Except as otherwise provided in a Participant's Award
                      Agreement, after the applicable Performance Period has
                      ended, the holder of Performance Shares shall be entitled
                      to receive payout on the number of Performance Shares
                      earned over the Performance Period, to be determined as a
                      function of the extent to which the corresponding
                      performance measures have been achieved. The Committee, in
                      its sole discretion, may pay Performance Shares in cash or
                      in Shares (or in a combination thereof) that have an
                      aggregate Fair Market Value equal to the value of the
                      earned Performance Shares.

         9.4. VOTING RIGHTS. A Participant shall have no voting rights with
respect to any Restricted Stock Units or Performance Shares granted hereunder.

         9.5. DIVIDEND EQUIVALENTS. At the discretion of the Committee, an Award
of Restricted Stock Units or Performance Shares may provide the Participant with
the right to receive Dividend Equivalents, which may be paid currently or
credited to an account for the Participant, and may be settled in cash and/or
Shares, as determined by the Committee in its sole discretion, subject in each
case to such terms and conditions as the Committee shall establish. Without
limiting the generality of the preceding sentence, if it is intended that an
Award of Restricted Stock Units/Performance Shares and/or the Dividend
Equivalents comply with the requirements of the Performance-Based Exception, the
Committee may apply any restrictions it deems appropriate to the payment of
Dividend Equivalents awarded with respect to such Restricted Stock
Units/Performance Shares, such that the Restricted Stock Units/Performance
Shares and/or Dividend Equivalents maintain eligibility for the
Performance-Based Exception.

         9.6. TERMINATION OF EMPLOYMENT OR SERVICE. Each Award Agreement shall
set forth the extent to which the Participant shall have the right to receive a
payout respecting an Award of Restricted Stock Units or Performance Shares
following termination of the Participant's employment or, if the Participant is
a Director or Consultant, service with the Company and its Subsidiaries. Such
provisions shall be determined in the sole discretion of the Committee, need not
be uniform among all Restricted Stock Units or Performance Shares, and may
reflect distinctions based on the reasons for termination of employment or
service.

                                       12
<PAGE>

         9.7. NONTRANSFERABILITY. Except as otherwise provided in a
Participant's Award Agreement, Restricted Stock Units and Performance Shares may
not be sold, transferred, pledged, assigned, or otherwise alienated or
hypothecated, other than by will or by the laws of descent and distribution.

ARTICLE 10.       OTHER AWARDS

         10.1. GRANT. The Committee shall have the right to grant other Awards
which may include, without limitation, the grant of deferred Shares, Shares or
cash based on attainment of performance or other goals established by the
Committee, or Shares in lieu of cash under other Company incentive or bonus
programs.

         10.2. PAYMENT OF OTHER AWARDS. Payment under or settlement of any such
Awards shall be made in such manner and at such times as the Committee may
determine.

         10.3. TERMINATION OF EMPLOYMENT OR SERVICE. The Committee shall
determine the extent to which the Participant shall have the right to receive
amounts under Awards granted under this Article 10 following termination of the
Participant's employment or, if the Participant is a Director or Consultant,
service with the Company and its Subsidiaries. Such provisions shall be
determined in the sole discretion of the Committee, such provisions may be
included in an agreement entered into with each Participant, need not be uniform
among all other Awards, and may reflect distinctions based on the reasons for
termination of employment or service.

         10.4. NONTRANSFERABILITY. Except as otherwise provided in a
Participant's Award Agreement, Awards granted under this Article 10 may not be
sold, transferred, pledged, assigned, or otherwise alienated or hypothecated,
other than by will or by the laws of descent and distribution.

ARTICLE 11.       PERFORMANCE MEASURES

         Unless and until the Company proposes for shareholder vote and
shareholders approve a change in the general performance measures set forth in
this Article 11, the performance goals to be used for Awards and any related
dividends or Dividend Equivalents that are designed to qualify for the
Performance-Based Exception shall be chosen from among the following performance
measure(s): earnings per share, economic value added, market share (actual or
targeted growth), net income (before or after taxes), operating income, adjusted
net income after capital charge, return on assets (actual or targeted growth),
return on capital (actual or targeted growth), return on equity (actual or
targeted growth), return on investment (actual or targeted growth), premiums
written or earned (gross, net or direct), revenue (actual or targeted growth),
loss ratio (gross or net), expense ratio (gross or net), combined ratio (gross
or net), share price, stock price growth, or total shareholder return. Awards
and any related dividends or Dividend Equivalents that are not designed to
qualify for the Performance-Based Exception may be based on these or such other
performance measures as the Committee may determine.

ARTICLE 12.       BENEFICIARY DESIGNATION

         Each Participant under the Plan may, from time to time, name any
beneficiary or beneficiaries (who may be named contingently or successively) to
whom any benefit under the Plan is to be paid in case of his or her death before
he or she receives any or all of such benefit. Each such designation shall
revoke all prior designations by the same Participant, shall be in a form
prescribed by the Committee, and will be effective only when filed by the
Participant in writing during the Participant's lifetime with the Committee. In
the absence of any such designation, benefits remaining unpaid at the
Participant's death shall be paid to the Participant's estate.

                                       13
<PAGE>

ARTICLE 13.       DEFERRALS

         If permitted by the Committee, a Participant may defer receipt of
amounts that would otherwise be provided to such Participant with respect to an
Award. If permitted, such deferral (and the required deferral election) shall be
made in accordance with, and shall be subject to, the terms and conditions of
the applicable nonqualified deferred compensation plan under which such deferral
is made and such other terms and conditions as the Committee may prescribe.

ARTICLE 14.       RIGHTS OF PARTICIPANTS

         14.1. CONTINUED SERVICE. Nothing in the Plan shall:

                  (A) interfere with or limit in any way the right of the
                      Company or a Subsidiary to terminate any Participant's
                      employment or service at any time,

                  (B) confer upon any Participant any right to continue in the
                      employ or service of the Company or any of its
                      Subsidiaries, nor

                  (C) confer on any Director any right to continue to serve on
                      the Board of Directors of the Company or any of its
                      Subsidiaries.

         14.2. PARTICIPATION. No Employee, Director or Consultant shall have the
right to be selected to receive an Award under the Plan, or, having been so
selected, to be selected to receive future Awards.

ARTICLE 15.       CHANGE IN CONTROL.

         Except as otherwise provided in a Participant's Award Agreement, upon
the occurrence of a Change in Control:

                  (A) any and all outstanding Options and SARs granted hereunder
                      shall become immediately exercisable;

                  (B) any Period of Restriction or other restriction imposed on
                      any Restricted Stock, Restricted Stock Unit or other Award
                      shall lapse; and

                  (C) any and all Performance Shares and other Awards (if
                      performance-based) shall be deemed earned at the target
                      level (or if no target level is specified, the maximum
                      level) with respect to all open Performance Periods.

                                       14
<PAGE>

         Unless a Participant's Award Agreement expressly provides otherwise, if
a Participant's employment or, if the Participant is a Director or Consultant,
service with the Company and its Subsidiaries is terminated following a Change
in Control, any of the Participant's Options or SARs that were outstanding on
the date of the Change in Control and that were vested as of the date of
termination of employment or service shall remain exercisable for a period
ending not before the earlier of the first anniversary of the termination of the
Participant's employment or service or the expiration of the stated term of the
Award.

ARTICLE 16.       AMENDMENT, MODIFICATION, AND TERMINATION

         16.1. AMENDMENT, MODIFICATION, AND TERMINATION. The Board may at any
time and from time to time, alter, amend, suspend or terminate the Plan in whole
or in part; provided, however, that no amendment which requires shareholder
approval in order for the Plan to comply with any applicable stock exchange
listing standards or any rule promulgated by the United States Securities and
Exchange Commission shall be effective unless such amendment shall be approved
by the requisite vote of shareholders of the Company entitled to vote thereon.

         16.2. ADJUSTMENT OF AWARDS UPON THE OCCURRENCE OF CERTAIN UNUSUAL OR
NONRECURRING EVENTS. The Committee may make adjustments in the terms and
conditions of, and the criteria included in, Awards in recognition of unusual or
nonrecurring events (including, without limitation, the events described in
Section 4.3 herein) affecting the Company or the financial statements of the
Company or of changes in applicable laws, regulations, or accounting principles,
whenever the Committee determines that such adjustments are appropriate in order
to prevent dilution or enlargement of the benefits or potential benefits
intended to be made available under the Plan. With respect to any Awards
intended to comply with the Performance-Based Exception, any such exception
shall be specified when the performance goals are established.

         16.3. AWARDS PREVIOUSLY GRANTED. No termination, amendment or
modification of the Plan or of any Award shall adversely affect in any material
way any Award previously granted under the Plan without the written consent of
the Participant holding such Award, unless such termination, modification or
amendment is required by applicable law and except as otherwise provided herein.

         16.4. COMPLIANCE WITH THE PERFORMANCE-BASED EXCEPTION. If changes are
made to Code Section 162(m) or regulations promulgated thereunder to permit
greater flexibility with respect to any Award or Awards available under the
Plan, the Committee may, subject to this Article 16, make any adjustments to the
Plan and/or Award Agreements it deems appropriate.

ARTICLE 17.       WITHHOLDING

         17.1. TAX WITHHOLDING. The Company shall have the power and the right
to deduct or withhold, or require a Participant to remit to the Company, an
amount sufficient to satisfy federal, state, and local taxes, domestic or
foreign, required by law or regulation to be withheld with respect to any
taxable event arising as a result of the Plan.

         17.2. USE OF SHARES TO SATISFY WITHHOLDING OBLIGATION. With respect to
withholding required upon the exercise of Options or SARs, upon the vesting of
Restricted Stock, Restricted Stock Units or Performance Shares, or upon any
other taxable event arising as a result of Awards granted hereunder,
Participants may elect that the withholding requirement be satisfied, in whole
or in part, by having the Company withhold, or by tendering to the Company,
Shares having a Fair Market Value equal to the minimum statutory withholding
(based on minimum applicable withholding rates for federal, state and local tax
purposes, including payroll taxes) that could be imposed on the transaction. Any
such elections by a Participant shall be irrevocable, made in writing and signed
by the Participant.

                                       15
<PAGE>

ARTICLE 18.       INDEMNIFICATION

         Each person who is or shall have been a member of the Committee, or of
the Board, shall be indemnified and held harmless by the Company to the fullest
extent permitted by Delaware law against and from any loss, cost, liability, or
expense that may be imposed upon or reasonably incurred by him or her in
connection with or resulting from any claim, action, suit, or proceeding to
which he or she may be a party or in which he or she may be involved by reason
of any action taken or failure to act under the Plan and against and from any
and all amounts paid by him or her in settlement thereof, with the Company's
approval, or paid by him or her in satisfaction of any judgment in any such
action, suit, or proceeding against him or her, provided he or she shall give
the Company an opportunity, at its own expense, to handle and defend the same
before he or she undertakes to handle and defend it on his or her own behalf.
The foregoing right of indemnification is subject to the person having been
successful in the legal proceedings or having acted in good faith and what is
reasonably believed to be a lawful manner in the Company's best interests. The
foregoing right of indemnification shall not be exclusive of any other rights of
indemnification to which such persons may be entitled under the Company's
Certificate of Incorporation or Bylaws (as the same may be amended and/or
restated from time to time), as a matter of law, or otherwise, or any power that
the Company may have to indemnify them or hold them harmless.

ARTICLE 19.       SUCCESSORS

         All obligations of the Company under the Plan and with respect to
Awards shall be binding on any successor to the Company, whether the existence
of such successor is the result of a direct or indirect purchase, merger,
consolidation, or other event, or a sale or disposition of all or substantially
all of the business and/or assets of the Company.

ARTICLE 20.       LEGAL CONSTRUCTION

         20.1. GENDER, NUMBER AND REFERENCES. Except where otherwise indicated
by the context, any masculine term used herein also shall include the feminine;
the plural shall include the singular and the singular shall include the plural.
Any reference in the Plan to an act or code or to any section thereof or rule or
regulation thereunder shall be deemed to refer to such act, code, section, rule
or regulation, as may be amended from time to time, or to any successor act,
code, section, rule or regulation.

         20.2. SEVERABILITY. In the event any provision of the Plan shall be
held illegal or invalid for any reason, the illegality or invalidity shall not
affect the remaining parts of the Plan, and the Plan shall be construed and
enforced as if the illegal or invalid provision had not been included.

                                       16
<PAGE>

         20.3. REQUIREMENTS OF LAW. The granting of Awards and the issuance of
Shares under the Plan shall be subject to all applicable laws, rules, and
regulations, and to such approvals by any governmental agencies or national
securities exchanges as may be required.

         20.4. GOVERNING LAW. To the extent not preempted by federal law, the
Plan, and all agreements hereunder, shall be construed in accordance with and
governed by the laws of the state of New York, without giving effect to any
conflicts or choice of law rule or principle that might otherwise refer
construction of the Plan and/or any agreements under the Plan to the substantive
law of another jurisdiction.

                                       17STOCK PURCHASE AGREEMENT

Stock Purchase Agreement, dated September __, 2004, between GENERAL COMPONENTS,
INC., a Nevada corporation having its business address at ______________ (the
"Company"), SIMON MU, an individual and the controlling shareholder of the
Company having an address at _______________________ ("Mu"), and Huntleigh
Investment Fund Limited, a St. Lucia company having its business address at c/o
Zetland Administration Limited, 13/F Silver Fortune Plaza, 1 Wellington Street,
Hong Kong (the "Purchaser").

                                   ARTICLE I

                       PURCHASE, SALE AND TERMS OF SHARES

      1.01 The Shares. On the date hereof, the Purchaser agrees to purchase
shares of Common Stock of the Company in the principal amount of $2,000,000 (the
"Funds"). The Company has authorized the issuance and sale of such number of
shares of its Common Stock, $.001 par value (such shares being referred to as
the "Shares"), as shall be issued at a purchase price per share equal to the
average of the closing sale price for the 10 trading days prior to the issuance
of the stock certificate(s) evidencing the purchase of such shares.
Notwithstanding the foregoing, under no circumstances shall the Purchaser
acquire more than 20% of the shares of Common Stock outstanding of the Company
immediately subsequent to the share exchange pursuant to the Exchange Agreement
(as defined herein) or the issuance of the Shares (assuming full conversion of
any preferred stock of the Company outstanding at such time) subject to the
terms and conditions hereof.

      1.02 Purchase Price and Closing. The Company agrees to issue, and sell to
the Purchaser and, in consideration of and in express reliance upon the
representations, warranties, covenants, terms and conditions of this Agreement,
the Purchaser agrees to purchase the Shares set forth in Section 1.01. The
closing of the purchase and sale of the Shares to be acquired by the Purchaser
from the Company under this Agreement shall take place at the location specified
by the Purchaser at 10:00 a.m., New York City time, simultaneous with the
closing of that certain Share Exchange Agreement dated ____, 2004 by and among
the Company, General Components, Inc., a Cayman Islands company ("GCI Cayman")
and certain shareholders of GCI Cayman (the "Exchange Agreement"), or at such
time and date thereafter as the Purchaser and the Company may agree (the
"Closing"). At the Closing, the Purchaser will make a payment of $1,750,000 of
the Funds, directly, by wire transfer or will cause Loeb & Loeb, as escrow
agent, to deliver a wire transfer of the Funds to the account of the Company.
Subsequent to the Closing and pursuant to the Company's having the requisite
number of authorized shares to issue to the Purchaser, the Company will issue a
stock certificate evidencing the purchase by the Purchaser of Common Stock of
the Company and the Purchaser will advance to the Company the remaining $250,000
of the Funds, directly, by wire transfer or will cause Loeb & Loeb, as escrow
agent, to deliver a wire transfer of the Funds to the account of the Company.

      1.03 Use of Proceeds. The Company shall use the cash proceeds from the
sale of the Shares in the manner set forth on Exhibit 1.03; provided that, the
Company may vary allocations a total of 10% across all categories.

      1.04 Representations by the Purchaser. Purchaser makes the following
representations and warranties to the Company:
<PAGE>

            (i) Purchaser is a company duly incorporated and validly existing
under the laws of St. Lucia and has all requisite corporate power and authority
to conduct its business in the manner in which it is presently being conducted.
The Purchaser has all requisite power and authority to execute, deliver and
perform this Agreement and to consummate the transaction contemplated hereby.
The execution delivery and performance of this Agreement and the consummation of
the transaction contemplated hereby have been duly authorized by the Boards of
Directors of Purchaser and no other corporate proceedings are necessary to
authorize the execution, delivery and performance of this Agreement or the
consummation of the transaction contemplated hereby. Assuming the due
authorization, execution and delivery of this Agreement by the Company, this
Agreement constitutes, the valid and legally binding obligations of the
Purchaser, enforceable against Purchaser in accordance with their terms, subject
to the effect of any applicable bankruptcy, moratorium, insolvency,
reorganization or other similar law affecting the enforceability of creditors'
rights generally and to the effect of general principles of equity which may
limit the availability of remedies, whether in a proceeding at law or in equity
(the "Bankruptcy Exception").

            (ii) The Purchaser, in making the decision to purchase the Shares,
has relied upon independent investigations made by it. The Purchaser has had a
reasonable opportunity to ask questions of and receive answers from the Company
concerning the Shares.

            (iii) The Purchaser has been supplied with or has sufficient access
to all information, including financial statements and other financial
information of the Company, and has been afforded with an opportunity to ask
questions of and receive answers concerning information to which a reasonable
investor would attach significance in making investment decisions, so that as a
reasonable investor the Purchaser has been able to make the Purchaser's decision
to purchase the Shares.

            (iv) The Purchaser has such knowledge and experience in financial,
tax and business matters so as to enable the Purchaser to utilize the
information made available to the Purchaser in connection with the offering of
the Shares to evaluate the merits and risks of an investment in the Shares and
to make an informed investment decision with respect thereto.

            (v) The Purchaser understands that the Shares are being and will be
sold in reliance on an exemption from the registration requirements of federal
and state securities laws under Regulation S and that the Company is relying
upon the truth and accuracy of the representations, warranties, agreements,
acknowledgments and understandings of the Purchaser set forth herein in order to
determine the applicability of such exemptions and the suitability of the
Purchaser to purchase the Shares. The representations, warranties and agreements
contained herein are true and correct as of the date hereof and may be relied
upon by the Company, and the Purchaser will notify the Company immediately of
any adverse change in any such representations and warranties which may occur
prior to the Closing.

                                       2
<PAGE>

            (vi) The Purchaser is not a U.S. person.

            (vii) All offers and sales of the Shares prior to the expiration of
the Distribution Compliance Period, as defined in Rule 902 promulgated under the
Securities Act shall only be made in compliance with the safe harbor contained
in Regulation S, pursuant to registration the Shares under the Securities Act or
pursuant to an exemption from registration under the Securities Act, and all
offers and sales made after the Distribution Compliance Period shall be made
only pursuant to such a registration or such exemption from registration.

            (viii) In the view of the Commission, the statutory basis for the
exemption claimed for this transaction would not be present if the offering of
the Shares, although in technical compliance with Regulation S, is part of a
plan or scheme to evade the registration provisions of the Securities Act. The
Purchaser is acquiring the Shares for investment purposes and has no present
intention to sell the Shares in the United States to a U.S. Person or for the
account or benefit of a U.S. Person.

            (ix) The purchaser agrees that the certificates representing the
Shares shall contain a legend to the following effect.

         THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
         UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE
         SECURITIES LAWS AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN
         MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED EXCEPT
         (1) IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S PROMULGATED UNDER
         THE SECURITIES ACT, AND BASED ON AN OPINION OF COUNSEL, WHICH COUNSEL
         AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT THE
         PROVISIONS OF REGULATION S HAVE BEEN SATISFIED (2) PURSUANT TO AN
         EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND
         APPLICABLE STATE SECURITIES LAWS OR (3) PURSUANT TO AN AVAILABLE
         EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND
         APPLICABLE STATE SECURITIES LAWS, IN WHICH CASE THE HOLDER MUST, PRIOR
         TO SUCH TRANSFER, FURNISH TO THE COMPANY AN OPINION OF COUNSEL, WHICH
         COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT
         SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE
         TRANSFERRED IN THE MANNER CONTEMPLATED PURSUANT TO AN AVAILABLE
         EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND
         APPLICABLE STATE SECURITIES LAWS. HEDGING TRANSACTIONS INVOLVING THE
         SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE CONDUCTED UNLESS
         IN COMPLIANCE WITH THE SECURITIES ACT.

                                       3
<PAGE>

            (x) Opinion. The Purchaser will not transfer any or all of the
Shares pursuant to Regulation S or absent an effective registration statement
under the Securities Act and applicable state securities law covering the
disposition of Purchaser's Shares, without first providing the Company with an
opinion of counsel (which counsel and opinion are reasonably satisfactory to the
Company) to the effect that such transfer will be made in compliance with
Regulation S or will be exempt from the registration and the prospectus delivery
requirements of the Securities Act and the registration or qualification
requirements of any applicable U.S. state securities laws.

            (xi) Brokers or Finders. No Person has or will have, as a result of
the transactions contemplated by this Agreement, any right, interest or valid
claim against or upon the Company for any commission, fee or other compensation
as a finder or broker because of any act or omission by such Purchaser or its
respective agents.

                                   ARTICLE II

                       CONDITIONS TO PURCHASER OBLIGATIONS

      The obligation of Purchaser to purchase and pay for the Shares to be
purchased by it at the Closing, is subject to the following conditions:

      2.01 Representations and Warranties. Each of the representations and
warranties of the Company set forth in Article III hereof shall be true,
accurate and correct on the date of the Closing as if made on the date of the
Closing and, as of the Closing Purchaser shall, in its sole discretion, be
satisfied with the results of its due diligence review of the Company and GCI
Cayman.

      2.02 Documentation at Closing. The Purchaser shall have received, prior to
or at the Closing, all of the following materials, each in form and substance
satisfactory to the Purchaser and its counsel, if any, and each of the following
events shall have occurred, or each of the following documents shall have been
delivered, prior to or simultaneous with each Closing:

            (a) Copies of (1) the Articles of Incorporation of the Company, as
amended or restated to date, together with such evidence as may be available of
the filing thereof; (2) the resolutions of the Board of Directors providing for
the approval of this Agreement, the issuance of the Shares, and all other
agreements or matters contemplated hereby or executed in connection herewith;
and (3) the By-laws of the Company, all of which shall have been certified by
the Secretary of the Company, as of the date of each such Closing, to be true,
complete and correct; and certified copies of all documents evidencing other
necessary corporate or other action and governmental approvals, if any, required
to be obtained at or prior to the Closing with respect to this Agreement and the
issuance of the Shares.

            (b) The Exchange Agreement shall be consummated in accordance with
its terms without amendment or other change and all conditions thereto have been
waived.

                                       4
<PAGE>

            (c) The Company shall have delivered the other documents,
instruments or certificates to be delivered pursuant to this Agreement by the
Company or any of its officers, the incumbency of such officers, and the true
specimen signatures of such officers.

            (d) A certificate of the President of the Company, dated the date of
the Closing, stating that the representations and warranties of the Company
contained in Article III hereof and otherwise made by the Company in writing in
connection with the transactions contemplated hereby are true and correct as of
the time of the Closing and that all obligations and covenants in this Agreement
required to be performed prior to or at the Closing have been performed as of
the time of Closing.

            (e) The Company shall have obtained any consents or waivers
necessary to be obtained at or prior to the Closing to execute and deliver this
Agreement and the other agreements and instruments executed and delivered by the
Company in connection herewith, to issue the Shares and to carry out the
transactions contemplated hereby and thereby, and such consents and waivers
shall be in full force and effect at the Closing. All corporate and other action
and governmental filings necessary to effectuate the terms of this Agreement and
the other agreements and instruments executed and delivered by the Company in
connection herewith and the issuance of the Shares shall have been made or
taken.

                                  ARTICLE III

                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

      The Company represents and warrants as follows:

      All of the representations and warranties of the Company set forth in
Article VI of the Exchange Agreement are true and correct and are, together with
the Schedules thereto, incorporated herein by reference in their entirety as if
made herein.

      3.01 Authorization. The Company has all requisite authority and power
(corporate and other), governmental licenses, authorizations, consents and
approvals to enter into this Agreement and each of the Transaction Documents to
which the Company is a party, to consummate the transactions contemplated by
this Agreement and each of the Transaction Documents to which the Company is a
party and to perform its obligations under this Agreement and each of the
Transaction Documents to which the Company is a party. The execution, delivery
and performance by the Company of this Agreement and each of the Transaction
Documents to which the Company is a party have been duly authorized by all
necessary corporate action and do not require from the Company Board or the
stockholders of the Company any consent or approval that has not been validly
and lawfully obtained. The execution, delivery and performance by the Company of
this Agreement and each of the Transaction Documents to which the Company is a
party requires no authorization, consent, approval, license, exemption of or
filing or registration with any Governmental Authority or other Person other
than customary filings with the Commission for transactions of the type
contemplated by this Agreement.

                                       5
<PAGE>

      3.02 No Violation. Neither the execution nor the delivery by the Company
of this Agreement or any Transaction Document to which the Company is a party,
nor the consummation or performance by the Company of the transactions
contemplated hereby or thereby will, directly or indirectly, (a) contravene,
conflict with, or result in a violation of any provision of the Organizational
Documents of the Company; (b) contravene, conflict with, constitute a default
(or an event or condition which, with notice or lapse of time or both, would
constitute a default) under, or result in the termination or acceleration of, or
result in the imposition or creation of any Lien under, any agreement or
instrument to which the Company is a party or by which the properties or assets
of the Company are bound; (c) contravene, conflict with, or result in a
violation of, any Law or Order to which the Company, or any of the properties or
assets owned or used by the Company, may be subject; or (d) contravene, conflict
with, or result in a violation of, the terms or requirements of, or give any
Governmental Authority the right to revoke, withdraw, suspend, cancel, terminate
or modify, any licenses, permits, authorizations, approvals, franchises or other
rights held by the Company or that otherwise relate to the business of, or any
of the properties or assets owned or used by, the Company, except, in the case
of clause (b), (c), or (d) above, for any such contraventions, conflicts,
violations, or other occurrences as would not have a Material Adverse Effect.

      3.03 Binding Obligations. Assuming this Agreement and the Transaction
Documents have been duly and validly authorized, executed and delivered by the
parties thereto other than the Company, this Agreement and each of the
Transaction Documents to which the Company is a party are duly authorized,
executed and delivered by the Company and constitute the legal, valid and
binding obligations of the Company, enforceable against the Company in
accordance with their respective terms, subject to the Bankruptcy Exception.

      3.04 Securities Laws. Assuming the accuracy of the representations and
warranties of the Purchaser contained in Section 1.04, the issuance of the
Shares pursuant to this Agreement are (a) exempt from the registration and
prospectus delivery requirements of the Securities Act, (b) have been registered
or qualified (or are exempt from registration and qualification) under the
registration permit or qualification requirements of all applicable state
securities laws, and (c) accomplished in conformity with all other applicable
federal and state securities laws.

      3.05 Capitalization and Related Matters.

            (a) Capitalization. The authorized capital stock of the Company
consists of 25,000,000 shares of the Company's Common Stock, of which 5,000,000
shares are issued and outstanding. All issued and outstanding shares of the
Company's Common Stock are duly authorized, validly issued, fully paid and
nonassessable, and have not been issued in violation of any preemptive or
similar rights. Except as disclosed in Schedule 3.07(a), there are no
outstanding options, warrants, purchase agreements, participation agreements,
subscription rights, conversion rights, exchange rights or other securities or
contracts that could require the Company to issue, sell or otherwise cause to
become outstanding any of its authorized but unissued shares of capital stock or
any securities convertible into, exchangeable for or carrying a right or option
to purchase shares of capital stock or to create, authorize, issue, sell or
otherwise cause to become outstanding any new class of capital stock. There are
no outstanding stockholders' agreements, voting trusts or arrangements,
registration rights agreements, rights of first refusal or other contracts
pertaining to the capital stock of the Company. The issuance of all of the
shares of Company's Common Stock described in this Section 3.07 have been in
compliance with U.S. federal and state securities laws.

                                       6
<PAGE>

            (b) No Redemption Requirements. Except as set forth in Schedule
3.07(b), there are no outstanding contractual obligations (contingent or
otherwise) of the Company to retire, repurchase, redeem or otherwise acquire any
outstanding shares of capital stock of, or other ownership interests in, the
Company or to provide funds to or make any investment (in the form of a loan,
capital contribution or otherwise) in any other Person.

            (c) Duly Authorized. The issuance of the Shares has been duly
authorized and, upon delivery to the Purchaser of a certificate or certificates
therefor in accordance with the terms of this Agreement, the Shares will have
been validly issued and fully paid, and will be nonassessable, have the rights,
preferences and privileges specified, will be free of preemptive rights and will
be free and clear of all Liens and restrictions, other than Liens created by the
Purchaser and restrictions on transfer imposed by this Agreement and the
Securities Act.

      3.06 Certain Proceedings. There is no pending Proceeding that has been
commenced against the Company and that challenges, or may have the effect of
preventing, delaying, making illegal, or otherwise interfering with, any of the
transactions contemplated by this Agreement. To the knowledge of the Company, no
such Proceeding has been threatened.

      3.07 Disclosure. Neither the Transaction Documents, the GCI Cayman
Financial Statements, nor any other agreement, document, certificate, statement,
whether oral or written, furnished to any of the Purchaser or its counsel by or
on behalf of the Company in connection with the transactions contemplated hereby
contains any untrue statement of a material fact or omits to state a material
fact necessary in order to make the statements contained herein or therein, in
light of the circumstances in which made, not misleading. There is no fact
within the knowledge of the Company's executive officers which has not been
disclosed herein or in writing by them to the Purchaser and which materially
adversely affects, or in the future in their opinion may, insofar as they can
now foresee, materially adversely affect the business, operations, properties,
Intellectual Property Rights, assets or condition, financial or other, of the
Company. Without limiting the foregoing, the Company has no knowledge that there
exists, or there is pending or planned, any patent, invention, device,
application or principle or any statute, rule, law, regulation, standard or code
which would materially adversely affect the business, operations, Intellectual
Property Rights, affairs or financial condition of the Company.

                                   ARTICLE IV

                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

      The Company represents and warrants as follows:

      4.01 Organizational Documents. True, correct and complete copies of the
Organizational Documents of each of the Subsidiaries have been delivered to the
Purchaser prior to the execution of this Agreement, and no action has been taken
to amend or repeal such Organizational Documents. None of the Subsidiaries is in
violation or breach of any of the provisions of its Organizational Documents,
except for such violations or breaches as would not have a Material Adverse
Effect.

      4.02 No Violation. Neither the execution nor the delivery by the Company
of this Agreement or any Transaction Document to which the Company is a party,
nor the consummation or performance by the Company of the transactions
contemplated hereby or thereby will, directly or indirectly, (a) contravene,
conflict with, or result in a violation of any provision of the Organizational
Documents of any of the Subsidiaries; (b) contravene, conflict with, constitute
a default (or an event or condition which, with notice or lapse of time or both,
would constitute a default) under, or result in the termination or acceleration
of, or result in the imposition or creation of any Lien under, any agreement or
instrument to which any of the Subsidiaries is a party or by which the
properties or assets of any of the Subsidiaries are bound; (c) contravene,
conflict with, or result in a violation of, any Law or Order to which any of the
Subsidiaries, or any of the properties or assets owned or used by any of the
Subsidiaries, may be subject; or (d) contravene, conflict with, or result in a
violation of, the terms or requirements of, or give any Governmental Authority
the right to revoke, withdraw, suspend, cancel, terminate or modify, any
licenses, permits, authorizations, approvals, franchises or other rights held by
any of the Subsidiaries or that otherwise relate to the business of, or any of
the properties or assets owned or used by, any of the Subsidiaries,

      4.03 except, in the case of clause (b), (c), or (d) above, for any such
contraventions, conflicts, violations, or other occurrences as would not have a
Material Adverse Effect.

      4.04 Binding Obligations. Assuming this Agreement and the Transaction
Documents have been duly and validly authorized, executed and delivered by the
parties thereto other than the Company, this Agreement and each of the
Transaction Documents to which the Company is a party are duly authorized,
executed and delivered by the Company and constitute the legal, valid and
binding obligations of the Company, enforceable against the Company in
accordance with their respective terms, subject to the Bankruptcy Exception.

      4.05 Subsidiaries. The capitalization of each Subsidiary of the Company is
as set forth on Schedule 4.04(d). The issued and outstanding shares of capital
stock of each Company Subsidiary set forth on such schedule have been duly
authorized and are validly issued and outstanding, fully paid and
non-assessable, and constitute all of the issued and outstanding capital stock
of such Company Subsidiary. The Company owns and has good, valid and marketable
title to, all shares of capital stock of such Subsidiaries. There are no
outstanding or authorized options, warrants, purchase agreements, participation
agreements, subscription rights, conversion rights, exchange rights or other
securities or contracts that could require any of the Subsidiaries to issue,
sell or otherwise cause to become outstanding any of its respective authorized
but unissued shares of capital stock or any securities convertible into,
exchangeable for or carrying a right or option to purchase shares of capital
stock or to create, authorize, issue, sell or otherwise cause to become
outstanding any new class of capital stock. There are no outstanding
stockholders' agreements, voting trusts or arrangements, registration rights
agreements, rights of first refusal or other contracts pertaining to the capital
stock of any of the Subsidiaries. None of the outstanding shares of capital
stock of any of the Company Subsidiaries has been issued in violation of any
rights of any Person or in violation of any Law.

      4.06 Compliance with Laws. Except as would not have a Material Adverse
Effect, the business and operations of each of the Subsidiaries have been and
are being conducted in accordance with all applicable Laws and Orders. Except as
would not have a Material Adverse Effect, no Company Subsidiary has received
notice of any violation (or any proceeding involving an allegation of any
violation) of any applicable Law or Order by or affecting the Subsidiaries and,
to the knowledge of the Company, no Proceeding involving an allegation of
violation of any applicable Law or Order is threatened or contemplated. Except
as would not have a Material Adverse Effect, no Company Subsidiary is subject to
any obligation or restriction of any kind or character, nor is there, to the
knowledge of the Company, any event or circumstance relating to any of the
Subsidiaries that materially and adversely affects in any way its business,
properties, assets or prospects or that prohibits the Company from entering into
this Agreement or would prevent or make burdensome its performance of or
compliance with all or any part of this Agreement or the consummation of the
transactions contemplated hereby.

                                       7
<PAGE>

      4.07 No Brokers or Finders. Except as disclosed in Schedule 4.06, no
Person has, or as a result of the transactions contemplated herein will have,
any right or valid claim against any of the Subsidiaries for any commission, fee
or other compensation as a finder or broker, or in any similar capacity.

      4.08 Absence of Undisclosed Liabilities. Except as set forth on Schedule
4.07, no Company Subsidiary has any debt, obligation or liability (whether
accrued, absolute, contingent, liquidated or otherwise, whether due or to become
due, whether or not known to the Company and each of its Subsidiaries) arising
out of any transaction entered into at or prior to the Closing Date or any act
or omission at or prior to the Closing Date, except to the extent set forth on
or reserved against on the GCI Cayman Financial Statements. Except as set forth
on Schedule 4.07, no Company Subsidiary has incurred any liabilities or
obligations under agreements entered into, in the usual and ordinary course of
business since December 31, 2003.

      4.09 Changes. Except as set forth on Schedule 4.08, no Company Subsidiary
has, since December 31, 2003:

            (a) Ordinary Course of Business. Conducted its business or entered
into any transaction other than in the usual and ordinary course of business,
except for the Exchange Agreement.

            (b) Adverse Changes. Suffered or experienced any change in, or
affecting, its condition (financial or otherwise), properties, assets,
liabilities, business, operations, results of operations or prospects other than
changes, events or conditions in the usual and ordinary course of its business,
none of which would have a Material Adverse Effect;

            (c) Loans. Made any loans or advances to any Person other than
travel advances and reimbursement of expenses made to employees, officers and
directors in the ordinary course of business;

            (d) Liens. Created or permitted to exist any Lien on any material
property or asset of any of the Subsidiaries, other than Permitted Liens;

            (e) Capital Stock. Except as contemplated by the Exchange Agreement,
issued, sold, disposed of or encumbered, or authorized the issuance, sale,
disposition or encumbrance of, or granted or issued any option to acquire any
shares of its capital stock or any other of its securities or any Equity
Security, or altered the term of any of its outstanding securities or made any
change in its outstanding shares of capital stock or its capitalization, whether
by reason of reclassification, recapitalization, stock split, combination,
exchange or readjustment of shares, stock dividend or otherwise;

                                       8
<PAGE>

            (f) Dividends. Declared, set aside, made or paid any dividend or
other distribution to any of its stockholders;

            (g) Material Subsidiary Contracts. Terminated or modified any
Material Subsidiary Contract, except for termination upon expiration in
accordance with the terms thereof;

            (h) Claims. Released, waived or cancelled any claims or rights
relating to or affecting any of the Subsidiaries in excess of $50,000 in the
aggregate or instituted or settled any Proceeding involving in excess of $50,000
in the aggregate;

            (i) Discharged Liabilities. Paid, discharged or satisfied any claim,
obligation or liability in excess of $50,000 in the aggregate, except for
liabilities incurred prior to the date of this Agreement in the ordinary course
of business;

            (j) Indebtedness. Created, incurred, assumed or otherwise become
liable for any Indebtedness in excess of $50,000 in the aggregate, other than
professional fees;

            (k) Guarantees. Guaranteed or endorsed in a material amount any
obligation or net worth of any Person;

            (l) Acquisitions. Except as contemplated by the Exchange Agreement,
acquired the capital stock or other securities or any ownership interest in, or
substantially all of the assets of, any other Person;

            (m) Accounting. Changed its method of accounting or the accounting
principles or practices utilized in the preparation of its financial statements,
other than as required by GAAP;

            (n) Agreements. Except as set forth on Schedule 4.08(n), entered
into any agreement, or otherwise obligated itself, to do any of the foregoing.

      4.10 Material Subsidiary Contracts.

            (a) The Company has made available to the Purchaser, prior to the
date of this Agreement, true, correct and complete copies of each written
Material Subsidiary Contract, including each amendment, supplement and
modification thereto.

                                       9
<PAGE>

            (b) No Defaults. Each Material Subsidiary Contract is a valid and
binding agreement of the Subsidiary that is the party thereto, and is in full
force and effect. Except as would not have a Material Adverse Effect, no Company
Subsidiary is in breach or default of any Material Subsidiary Contract to which
it is a party and, to the knowledge of the Company, no other party to any
Material Subsidiary Contract is in breach or default thereof. Except as would
not have a Material Adverse Effect, no event has occurred or circumstance exists
that (with or without notice or lapse of time) would (a) contravene, conflict
with or result in a violation or breach of, or become a default or event of
default under, any provision of any Material Subsidiary Contract or (b) permit
any of the Subsidiaries or any other Person the right to declare a default or
exercise any remedy under, or to accelerate the maturity or performance of, or
to cancel, terminate or modify any Material Subsidiary Contract. None of the
Subsidiaries has received notice of the pending or threatened cancellation,
revocation or termination of any Material Subsidiary Contract to which it is a
party. There are no renegotiations of, or attempts to renegotiate, or
outstanding rights to renegotiate any material terms of any Material Subsidiary
Contract.

      4.11 Employees.

            (a) Except as would not have a Material Adverse Effect, each of the
Subsidiaries is in full compliance with all Laws regarding employment, wages,
hours, benefits, equal opportunity, collective bargaining, the payment of
benefits and other taxes, occupational safety and health and plant closing. None
of the Subsidiaries is liable for the payment of any compensation, damages,
taxes, fines, penalties or other amounts, however designated, for failure to
comply with any of the foregoing Laws.

            (b) No director, officer or employee of any of the Subsidiaries is a
party to, or is otherwise bound by, any contract (including any confidentiality,
noncompetition or proprietary rights agreement) with any other Person that in
any way adversely affects or will materially affect (a) the performance of his
or her duties as a director, officer or employee of any of the Subsidiaries or
(b) the ability of any of the Subsidiaries to conduct its business. Except as
set forth on Schedule 4.10(b), each employee of each of the Subsidiaries is
employed on an at-will basis and no Company Subsidiary has any contract with any
of its employees which would interfere with such Subsidiaries' ability to
discharge its employees.

      4.12 Tax Returns. Each of the Subsidiaries has filed all material Tax
Returns required to be filed by or on behalf of each of the Subsidiaries and
have paid all material Taxes of each of the Subsidiaries required to have been
paid (whether or not reflected on any Tax Return). Except as set forth on
Schedule 4.11, (a) no Governmental Authority in any jurisdiction has made a
claim, assertion or threat to any of the Subsidiaries that such Subsidiary is or
may be subject to taxation by such jurisdiction; (b) there are no Liens with
respect to Taxes on any of the Subsidiaries' property or assets other than
Permitted Liens; and (c) there are no Tax rulings, requests for rulings, or
closing agreements relating to any of the Subsidiaries for any period (or
portion of a period) that would affect any period after the date hereof.

      4.13 Material Assets. The financial statements of the Subsidiaries set
forth in the GCI Cayman Financial Statements reflect the material properties and
assets (real and personal) owned or leased by each of the Subsidiaries.

      4.14 Litigation; Orders. Except as set forth on Schedule 4.13, there is no
Proceeding (whether federal, state, local or foreign) pending or, to the
knowledge of the Company, threatened against or affecting any of the
Subsidiaries or the Subsidiaries' properties, assets, business or employees. To
the knowledge of the Company, there is no fact that might result in or form the
basis for any such Proceeding. None of the Subsidiaries is subject to any
Orders.

                                       10
<PAGE>

      4.15 Licenses. Except as would not have a Material Adverse Effect, each of
the Subsidiaries possesses from the appropriate Governmental Authority all
licenses, permits, authorizations, approvals, franchises and rights that are
necessary for each of the Subsidiaries to engage in its business as currently
conducted or as proposed to be conducted and to permit each of the Subsidiaries
to own and use its properties and assets in the manner in which it currently
owns and uses such properties and assets (collectively, "Subsidiary Permits").
None of the Subsidiaries has received notice from any Governmental Authority or
other Person that there is lacking any license, permit, authorization, approval,
franchise or right necessary for each of the Subsidiaries to engage in its
business as currently conducted and to permit the Subsidiaries to own and use
its properties and assets in the manner in which it currently owns and uses such
properties and assets. Except as would not have a Material Adverse Effect, the
Subsidiary Permits are valid and in full force and effect. Except as would not
have a Material Adverse Effect, no event has occurred or circumstance exists
that may (with or without notice or lapse of time): (a) constitute or result,
directly or indirectly, in a violation of or a failure to comply with any
Subsidiary Permit; or (b) result, directly or indirectly, in the revocation,
withdrawal, suspension, cancellation or termination of, or any modification to,
any Subsidiary Permit. None of the Subsidiaries has received notice from any
Governmental Authority or any other Person regarding: (x) any actual, alleged,
possible or potential contravention of any Subsidiary Permit; or (y) any actual,
proposed, possible or potential revocation, withdrawal, suspension,
cancellation, termination of, or modification to, any Subsidiary Permit. All
applications required to have been filed for the renewal of such Subsidiary
Permits have been duly filed on a timely basis with the appropriate Persons, and
all other filings required to have been made with respect to such Subsidiary
Permits have been duly made on a timely basis with the appropriate Persons. All
Subsidiary Permits are renewable by their terms or in the ordinary course of
business without the need to comply with any special qualification procedures or
to pay any amounts other than routine fees or similar charges, all of which
have, to the extent due, been duly paid.

      4.16 Interested Party Transactions. Except as disclosed in Schedule 4.15,
no officer, director or stockholder of any of the Subsidiaries or any Affiliate
or "associate" (as such term is defined in Rule 405 of the Commission
promulgated under the Securities Act) of any such Person, has or has had, either
directly or indirectly, (a) an interest in any Person which (i) furnishes or
sells services or products which are furnished or sold or are proposed to be
furnished or sold by any of the Subsidiaries, or (ii) purchases from or sells or
furnishes to, or proposes to purchase from, sell to or furnish any of the
Subsidiaries any goods or services; or (b) a beneficial interest in any contract
or agreement to which any of the Subsidiaries is a party or by which it may be
bound or affected.

      4.17 Title to and Condition of Properties. Except as would not have a
Material Adverse Effect, each of the Subsidiaries owns (with good and marketable
title in the case of real property) or holds under valid leases or other rights
to use all real property, plants, machinery, equipment and other personal
property necessary for the conduct of its business as presently conducted, free
and clear of all Liens, except Permitted Liens. The material buildings, plants,
machinery and equipment necessary for the conduct of the business of each of the
Subsidiaries as presently conducted are structurally sound, are in good
operating condition and repair and are adequate for the uses to which they are
being put, and none of such buildings, plants, machinery or equipment is in need
of maintenance or repairs, except for ordinary, routine maintenance and repairs
that are not material in nature or cost.

                                       11
<PAGE>

      4.18 Financial Statements. The GCI Cayman Financial Statements were
prepared in accordance with GAAP applied on a consistent basis during the
periods involved (except as may be indicated in the notes thereto), and fairly
present in all material respects (subject in the case of unaudited statements,
to normal, recurring audit adjustments) the consolidated financial position of
GCI Cayman as at the dates thereof and the results of its operations and cash
flows for the periods then ended. The Company has, and has no reasonable grounds
to know of, any liability, contingent or otherwise, not adequately reflected in
or reserved against in the GCI Financial Statements. Except as set forth in
Schedule 4.17, since December 31, 2003, (i) there has been no material adverse
change in the business, assets, operations, affairs, prospects or financial
condition of the Subsidiaries; (ii) neither the business, financial condition,
operations, prospects or affairs of the Subsidiaries nor any of their respective
properties or assets, including without limitation, its Intellectual Property
Rights, have been materially adversely affected as the result of any legislative
or regulatory change, any revocation or change in any franchise, permit, license
or right to do business, or any other event or occurrence, whether or not
insured against; and (iii) neither of the Subsidiaries has entered into any
material transaction other than in the ordinary course of business, made any
distribution on its capital stock, or redeemed or repurchased or declared any
distribution on, any of its capital stock.

      4.19 Stock Option Plans; Employee Benefits.

            (a) Except as set forth in Schedule 4.18, no Subsidiary maintains
any stock option or other plans providing for the grant by the Company or such
Subsidiary of stock options to directors, officers, employees or other Persons.

            (b) Except as set forth in Schedule 4.18, none of the Subsidiaries
has any employee benefit plans or arrangements covering their present and former
employees or providing benefits to such persons in respect of services provided
to the Subsidiaries.

            (c) Neither the consummation of the transactions contemplated hereby
alone, nor in combination with another event, with respect to each director,
officer, employee and consultant of the Subsidiaries, will result in (i) any
payment (including, without limitation, severance, unemployment compensation or
bonus payments) becoming due from any Subsidiary, (ii) any increase in the
amount of compensation or benefits payable to any such individual or (iii) any
acceleration of the vesting or timing of payment of compensation payable to any
such individual. No agreement, arrangement or other contract of any Subsidiary
provides benefits or payments contingent upon, triggered by, or increased as a
result of a change in the ownership or effective control of any Subsidiary.

      4.20 Environmental and Safety Matters. Except as set forth on Schedule
4.19 and except as would not have a Material Adverse Effect:

            (a) Each of the Subsidiaries has at all times been and is in
compliance with all Environmental Laws applicable to any of the Subsidiaries.

            (b) There are no Proceedings pending or threatened against any of
the Subsidiaries alleging the violation of any Environmental Law or
Environmental Permit applicable to any of the Subsidiaries or alleging that any
Subsidiary is a potentially responsible party for any environmental site
contamination.

                                       12
<PAGE>

            (c) Neither this Agreement nor the consummation of the transactions
contemplated by this Agreement shall impose any obligations to notify or obtain
the consent of any Governmental Authority or third Persons under any
Environmental Laws applicable to any of the Subsidiaries.

      4.21 Money Laundering Laws. The operations of the Subsidiaries are and
have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign
Transactions Reporting Act of 1970, as amended, the money laundering statutes of
all U.S. and non-U.S. jurisdictions, the rules and regulations thereunder and
any related or similar rules, regulations or guidelines, issued, administered or
enforced by any Governmental Authority (collectively, the "Money Laundering
Laws") and no Proceeding involving any of the Subsidiaries with respect to the
Money Laundering Laws is pending or, to the knowledge of the Company,
threatened.

      4.22 Certain Agreements of Officers and Employees.

            (a) No officer, employee or consultant of any of the Subsidiaries
is, or, to the Company's knowledge, is now anticipated to be, in violation of
any material term of any employment contract, patent disclosure agreement,
proprietary information agreement, noncompetition agreement, nonsolicitation
agreement, confidentiality agreement, or any other similar contract or agreement
or any restrictive covenant, relating to the right of any such officer,
employee, or consultant to be employed or engaged by any Subsidiary because of
the nature of the business conducted or to be conducted by any Subsidiary or
relating to the use of trade secrets or proprietary information of others, and
to the Company's knowledge and belief, the continued employment or engagement of
the Subsidiaries' officers, employees or consultants does not subject the
Subsidiaries or the Company to any liability with respect to any of the
foregoing matters.

            (b) No officer, consultant or employee of any of the Subsidiaries
whose termination, either individually or in the aggregate, could have a
Material Adverse Effect on any of the Subsidiaries, has terminated since the
date hereof; or to the best knowledge of the Company, has any present intention
of terminating, his employment or engagement with any Subsidiary, nor has any
such person been, or been proposed to be terminated by any Subsidiary.

      4.23 Compliance with Other Instruments. Each of the Subsidiaries is in
compliance in all respects with the terms and provisions of this Agreement and
of its Articles of Incorporation and By-laws, each as amended and/or restated to
date, and in all respects with the material terms and provisions of all
mortgages, indentures, leases, agreements and other instruments by which it is
bound or to which it or any of its properties or assets are subject. Each of the
Subsidiaries is in compliance in all material respects with all judgments,
decrees, governmental orders, laws, statutes, rules or regulations by which it
is bound or to which it or any of its properties or assets are subject. Neither
the execution and delivery of the Transaction Documents nor the issuance of the
Shares nor the consummation or performance of any transaction contemplated
hereby or thereby, has constituted or resulted in or will constitute or result
in a default or violation of; create a conflict with, trigger any "change of
control" or other right of any Person under, or require any consent, waiver,
release or approval under or with respect to, any term or provision of any of
the foregoing documents, instruments, judgments, agreements, decrees, orders,
statutes, rules and regulations.

                                       13
<PAGE>

      4.24 Title to Assets; Patents. (a) Each of the Subsidiaries has good and
marketable title in fee to such of its fixed assets as are real property, and
good and merchantable title to all of its other assets, now carried on its
books, which assets consist of those reflected in the GCI Financial Statements
or acquired since the date of such balance sheet (except personal property
disposed of since said date in the ordinary course of business) free of any
mortgages, pledges, charges. liens, security interests or other encumbrances.
Each of the Subsidiaries enjoys peaceful and undisturbed possession under all
leases under which it is operating, and all said leases are valid and subsisting
and in full force and effect.

            (a) Each of the Subsidiaries owns or has a valid right to use the
Intellectual Property Rights being used to conduct its business as now operated
and as now proposed by the Subsidiaries to be operated and the conduct of its
business as now operated and as now proposed to be operated does not and will
not conflict with or infringe upon the Intellectual Property rights of others.
Except as set forth on Schedule 4.23, no claim is pending or threatened against
the Subsidiaries and/or their officers, employees and consultants to the effect
that any such Intellectual Property Right owned or licensed by the Subsidiaries,
or which the Subsidiaries otherwise have the right to use, is invalid or
unenforceable by the Subsidiaries. The Subsidiaries have no obligation to
compensate any Person for the use of any such Intellectual Property Rights and
none of the Subsidiaries has granted any Person any license or other right to
use any of the Intellectual Property Rights of any Subsidiary, whether requiring
payment of royalties or not.

            (b) Each of the Subsidiaries has taken all reasonable measures to
protect and preserve the security, confidentiality and value of its Intellectual
Property Rights, including its trade secrets and other confidential information.
All employees and consultants of the Subsidiaries involved in the design,
review, evaluation or development of products or Intellectual Property Rights
have executed a nondisclosure and assignment of inventions agreements
sufficient, to the extent permitted by law, to protect the confidentiality and
value of the Subsidiaries' Intellectual Property Rights and to vest in the
Subsidiaries exclusive ownership of such Intellectual Property Rights. All trade
secrets and other confidential information of Subsidiaries are presently valid
and protectible and are not part of the public domain or knowledge, nor, to the
best knowledge of the Company, have they been used, divulged or appropriated for
the benefit of any person other than the Subsidiaries or otherwise to the
detriment of the Subsidiaries. To the best of the Company's knowledge, no
employee or consultant of the Subsidiaries has used any trade secrets or other
confidential information of any other person in the course of their work for the
Subsidiaries. Except as set forth on Schedule 4.23(b), a Subsidiary is and will
be the exclusive owner of all right, title and interest in its Intellectual
Property Rights as purported to be owned by the Company or such Subsidiary, and
such Intellectual Property Rights are valid and in full force and effect. Except
as set forth on Schedule 4.23, none of the Subsidiaries, nor any of its
employees or consultants has received notice of, and to the best of the
Company's knowledge there are no claims that the Subsidiaries' Intellectual
Property Rights or the use or ownership thereof by the Subsidiaries infringes,
violates or conflicts with any such right of any third party. Except as set
forth on Schedule 4.23(b), no university, hospital, government agency (whether
federal or state) or other organization which sponsored research and development
conducted by any Subsidiary has any claim of right to or ownership of or other
encumbrance upon the Intellectual Property Rights purported to be owned by the
Subsidiaries.

                                       14
<PAGE>

      4.25 Assumptions or Guaranties of Indebtedness of Other Persons. None of
the Subsidiaries has assumed, guaranteed, endorsed, or otherwise become directly
or contingently liable on (including, without limitation, liability by way of
agreement, contingent or otherwise, to purchase, to provide funds for payment,
to supply funds to or otherwise invest in the debtor or otherwise to assure the
creditor against loss), any Indebtedness of any other Person except as set forth
in Schedule 4.24.

      4.26 Investments in Other Persons. Except as set forth in Schedule 4.25,
none of the Subsidiaries has made any loans or advances to any Person which is
outstanding on the date of this Agreement in excess of $10,000 in the aggregate,
nor is it committed or obligated to make any such loan or advance, nor has or
does any Subsidiary own any capital stock, assets comprising the business of;
obligations of; or any interest in, any Person.

      4.27 Brokers or Finders. No Person has or will have, as a result of the
transactions contemplated by this Agreement, any right, interest or valid claim
against or upon any of the Subsidiaries for any commission, fee or other
compensation as a finder or broker because of any act or omission by any of the
Subsidiaries or their respective agents.

      4.28 Disclosure. There is no fact within the knowledge of the Company
relating to the Subsidiaries has not been disclosed herein or in writing by them
to the Purchaser and which materially adversely affects, or in the future in
their opinion may, insofar as they can now reasonably foresee, materially
adversely affect the business, operations, properties, Intellectual Property
Rights, assets or condition, financial or other, of the Subsidiaries.

                                   ARTICLE V

                            COVENANTS OF THE COMPANY

      5.01 Operations. From and after the date hereof through the Closing the
Company will operate only in the ordinary course of business and in addition
thereto, and not in limitation thereof; will not and will not permit or suffer
any Subsidiary to: (i) voluntarily incur any obligation; (ii) declare, authorize
or become obligated to make (or express any intention to make) any distribution,
dividend, increase in compensation or bonus to any Person; (iii) enter into a
binding contract or arrangement; (iv) incur any Indebtedness; (v) engage in a
transaction with any Affiliate; (vi) issue or redeem any debt or equity
securities; (vii) grant any lien or encumbrance; (viii) amend any of its
agreements, contracts, articles of incorporation or by-laws; (ix) sell any
assets; or (x) agree to do any of the foregoing.

      5.02 Inspection. The Company shall permit authorized representatives of
the Purchaser to visit and inspect any of the properties of the Company,
including its books of account (and to make copies thereof and take extracts
therefrom), and to discuss its affairs, finances and accounts with its officers,
employees, independent accountants, consultants and attorneys, all at such
reasonable times and as often as may be reasonably requested.

                                       15
<PAGE>

                                   ARTICLE VI

                                  FIRST REFUSAL

      6.01 Right of First Refusal. Before the Company shall issue, sell or
exchange, agree or obligate itself to issue, sell or exchange, or reserve or set
aside for issuance, sale or exchange (unless, in the case of an agreement,
obligation, reservation or setting aside, the same is expressly subject to the
rights of the Purchaser under the provisions of this Article VI), any (i) shares
of Common Stock, (ii) any other equity security of the Company, including
without limitation, shares of any series of the Company's class of preferred
stock (iii) any convertible debt security of the Company, including without
limitation, any debt security which by its terms is convertible into or
exchangeable for any equity security of the Company, (iv) any security of the
Company that is a combination of debt and equity, the Company shall, in each
case, first offer to sell such securities (the "Offered Securities") to the
Purchaser at a price and on such other terms as shall have been specified by the
Company in writing delivered to the Purchaser (in each case, the "Offer") (which
price and terms shall, unless otherwise consented to by the Purchaser in
writing, be a price and on terms of a bona fide third party offer obtained by
the Company), which Offer by its terms shall remain open and irrevocable for a
period of twenty (20) days from the transmission of the Offer by the Company.

      6.02 Notice of Acceptance. Notice of each Purchaser's intention to accept,
in whole or in part, any Offer made pursuant to Section 6.01 shall be evidenced
by a writing, signed by such Purchaser and delivered to the Company prior to the
end of the 20-day period of such Offer, setting forth the amount of such
Securities that the Purchaser elects to purchase (the "Notice of Acceptance").

      6.03 Conditions to Acceptances and Purchase.

            (a) Permitted Sales of Refused Securities. In the event that a
Notice of Acceptance is not given in respect of all the Offered Securities, the
Company shall have one hundred thirty five (135) days from the end of said
20-day period to sell any such Offered Securities as to which a Notice of
Acceptance has not been given by the Purchaser (the "Refused Securities") to the
Person or Persons specified in the Offer, but only for an amount and kind (or
the cash equivalent thereof)of consideration and otherwise in all respects upon
the terms and conditions, including, without limitation, unit price and interest
rates, which are no more favorable, in the aggregate, to such other Person or
Persons or less favorable to the Company (as determined in good faith by the
Board of Directors) than those set forth in the Offer.

            (b) Reduction in Amount of Offered Securities. In the event the
Company shall propose to sell less than all of the Refused Securities (any such
sale to be in the manner and on the terms specified in Section 6.03(a) above),
then the Purchaser may reduce the number of shares or other shares of the
Offered Securities specified in its Notices of Acceptance to an amount which
shall be not less than the amount of the Offered Securities which the Purchaser
elected to purchase pursuant to Section 6.02 multiplied by a fraction, (i) the
numerator of which shall be the amount of Offered Securities which the Company
actually proposes to sell, and (ii) the denominator of which shall be the amount
of all Offered Securities. In the event that the Purchaser so elects to reduce
the number or amount of Offered Securities specified in its Notice of
Acceptance, the Company may not sell or otherwise dispose of more than the
reduced amount of the Offered Securities until such securities have again been
offered to the Purchaser in accordance with Section 6.01.

                                       16
<PAGE>

            (c) Closing. At the closing of the sale to such other Person or
Persons of all or less than all the Refused Securities, which closing shall
include payment of the purchase price therefor as set forth in Section 1.02
hereof, the Purchaser shall purchase from the Company, and the Company shall
sell to the Purchaser, the number of Offered Securities specified in the Notices
of Acceptance, as reduced pursuant to Section 6.03(b) if the Purchaser have so
elected, upon the terms and conditions specified in the Offer, including,
without limitation, payment in full for such Offered Securities. The purchase by
the Purchaser of any Offered Securities is subject in all cases to the
preparation, execution and delivery by the Company and the Purchaser of a
purchase agreement relating to such Offered Securities in form and substance as
offered to the purchaser or proposed purchaser of the Offered Securities who are
not the Purchaser.

      6.04 Further Sale. In each case, any Offered Securities not purchased by
the Purchaser or other Person or Persons in accordance with Section 6.03 may not
be sold or otherwise disposed of until they are again offered to the Purchaser
under the procedures specified in Section 6.01, 6.02 and 6.03.

      6.05 Exceptions. The rights of the Purchaser under this Article VIII shall
not apply to:

            (i) Common Stock issued as a stock dividend to holders of Common
Stock or upon any subdivision or combination of shares of Common Stock;

            (ii) the Shares or the shares of Common Stock to be issued pursuant
to the Exchange Agreement;

            (iii) securities described in clause (i) through (v) of Section 6.01
which are to be issued as all or part of the consideration in a business
combination involving the acquisition by the Company of all or part of the stock
(or other equity interest), business or assets of another Person.

                                  ARTICLE VII

                            INDEMNIFICATION; REMEDIES

      7.01 Survival. All representations, warranties, covenants, and obligations
in this Agreement shall survive the Closing and expire six months from the date
hereof (the "Survival Period").

      7.02 Indemnification by the Company. From and after the Closing until (1)
the expiration of the Survival Period, or (2) with respect to a specific claim
made by the Purchaser against the Company prior to the expiration of the
Survival Period, until a court of competent jurisdiction renders a final
unappealable decision (or appeals of a decision are not taken within the time
period permitted for filing same) (the "Claims Period"), the Company shall
indemnify and hold harmless the Purchaser from and against any liabilities,
loss, claims, damages (excluding consequential, punitive and other similar
damages), fines, penalties, expenses (including costs of investigation and
defense and reasonable attorneys' fees) or diminution of value (collectively,
"Damages") arising, directly or indirectly, from or in connection with:

                                       17
<PAGE>

            (i) any breach of any representation or warranty made by the Company
in this Agreement or in any certificate delivered by the Company pursuant to
this Agreement;

            (ii) any breach by the Company of any covenant or obligation of the
Company in this Agreement required to be performed by the Company on or prior to
Closing; or

      The amount of any and all Damages suffered by a Purchaser shall be
recovered by the issuance to the Purchaser of a specified number of additional
shares of Company Common Stock (the "Additional Shares"), the amount of which
shall be determined in accordance with Section 7.03 below.

      7.03 Issuance of Additional Shares. The number of Additional Shares to be
issued to the Purchaser pursuant to Section 7.02 shall be equal to the aggregate
amount of the Damages suffered by the Purchaser, divided by the market value of
the Company Common Stock to be calculated using the average of the closing bid
price as quoted on the Over the Counter Bulletin Board (or such other public
trading market on which the Company's Common Stock may be trading at such time)
for the thirty (30) trading days immediately prior to the date that such amount
of Damages is determined by a court of competent jurisdiction or pursuant to a
binding settlement agreement among the Company and the Purchaser (the "Market
Value").

      7.04 Limitations on Amount. The Purchaser shall not be entitled to
indemnification pursuant to Section 7.02, unless and until the aggregate amount
of Damages to the Purchaser with respect to such matters under Section 7.02
exceeds $100,000, at which time, subject to the following cap on the maximum
number of Additional Shares to be issued to the Purchaser, the Purchaser shall
be entitled to indemnification for the total amount of such Damages in excess of
$100,000. The aggregate number of Additional Shares to be issued to the
Purchaser shall not exceed the lesser of (i) such number of Additional Shares
based on the Market Value equal to $8,000,000 or (ii) such number of Additional
Shares that when issued would decrease the percentage of securities of the
Company held by the Company's Shareholders, whether in shares of Common Stock or
on shares acquired on an as-converted basis, to less than 51% of the aggregate
capitalization of the Company.

      7.05 Determining Damages. Materiality qualifications to the
representations and warranties of the Company shall be taken into account in
determining the amount of Damages occasioned by a breach of any such
representation or warranty for purposes of determining the whether the baskets
set forth in 7.04 have been met.

                                       18
<PAGE>

                                  ARTICLE VIII

                                    GLOSSARY

      8.01 Certain Defined Terms. As used in this Agreement, the following terms
shall have the following meanings (such meanings to be equally applicable to
both the singular and plural forms of the terms defined):

            "Additional Shares" shall have the meaning assigned to that term in
Section 7.02(b).

            "Affiliate" of any person shall mean a Person controlling,
controlled by or under common control with, any such Person.

            "Agreement" means this Stock Purchase Agreement as from time to time
amended and in effect between the parties, including all Exhibits hereto.

            "Board of Directors" or "Board" means the board of directors of the
Company as constituted from time to time.

            "Claims Period" shall have the meaning assigned to that term in
Section 7.02.

            "Closing" shall have the meaning assigned to that term in Section
1.02.

            "Code" means the Internal Revenue Code of 1986, as amended.

            "Commission" shall mean the United States Securities and Exchange
Commission or any other federal agency at the time administering the Securities
Act or the Exchange Act.

            "Common Stock" includes (a) the Company's Common Stock, $.001 par
value, as authorized on the date of this Agreement, (b) any other capital stock
of any class or classes (however designated) of the Company authorized on or
after the date hereof, the holders of which shall have the right, without
limitation as to amount, either to all or to a share of the balance of current
dividends and liquidating dividends after the payment of dividends and
distributions on any shares entitled to a preference, and the holders of which
shall ordinarily, in the absence of contingencies or in the absence of any
provision to the contrary in the Company's Certificate of Incorporation, be
entitled to vote for the election of a majority of directors of the Company
(even though the right so to vote has been suspended by the happening of such a
contingency or provision), and (c) any other securities into which or for which
any of the securities described in (a) or (b) may be converted or exchanged
pursuant to a plan of recapitalization, reorganization, merger, sale of assets
or otherwise.

            "Consolidated" and "consolidating" when used with reference to any
term defined herein mean that term as applied to the accounts of the Company
and/or its Subsidiaries consolidated in accordance with GAAP consistently
applied throughout reporting periods.

            "Damages" shall have the meaning assigned to that term in Section
7.02.

                                       19
<PAGE>

            "Environmental Laws" means any Law or other requirement relating to
the environment, natural resources, or public or employee health and safety.

            "Environmental Permit" means all licenses, permits, authorizations,
approvals, franchises and rights required under any applicable Environmental Law
or Order.

            "Equity Security" means any stock or similar security, including,
without limitation, securities containing equity features and securities
containing profit participation features, or any security convertible into or
exchangeable for, with or without consideration, any stock or similar security,
or any security carrying any warrant, right or option to subscribe to or
purchase any shares of capital stock, or any such warrant or right.

            "Exchange Act" means the Securities Exchange Act of 1934, as
amended, or any similar federal statute, and the rules and regulations of the
Commission (or of any other Federal agency then administering the Exchange Act)
thereunder, all as the same shall be in effect at the time.

            "GCI Cayman Financial Statements" mean _________________________.

            "Governmental Authority" means any federal or national, state or
provincial, municipal or local government, governmental authority, regulatory or
administrative agency, governmental commission, department, board, bureau,
agency or instrumentality, political subdivision, commission, court, tribunal,
official, arbitrator or arbitral body, in each case whether U.S. or non-U.S.

            "Indebtedness" means (i) any liability for borrowed money or
evidenced by a note or similar obligation given in connection with the
acquisition of any property or other assets (other than trade accounts payable
incurred in the ordinary course of business); (ii)all guaranties, endorsements
and other contingent obligations, in respect of Indebtedness of others, whether
or not the same are or should be reflected in the Company's balance sheet (or
the notes thereto), except guaranties by endorsement of negotiable instruments
for deposit or collection or similar transactions in the ordinary course of
business, and (iii) all obligations under leases required to be capitalized in
accordance with GAAP.

            "Intellectual Property" means all industrial and intellectual
property, including, without limitation, all U.S. and non-U.S. patents, patent
applications, patent rights, trademarks, trademark applications, common law
trademarks, Internet domain names, trade names, service marks, service mark
applications, common law service marks, and the goodwill associated therewith,
copyrights, in both published and unpublished works, whether registered or
unregistered, copyright applications, franchises, licenses, know-how, trade
secrets, technical data, designs, customer lists, confidential and proprietary
information, processes and formulae, all computer software programs or
applications, layouts, inventions, development tools and all documentation and
media constituting, describing or relating to the above, including manuals,
memoranda, and records, whether such intellectual property has been created,
applied for or obtained anywhere throughout the world.

                                       20
<PAGE>

            "Laws" means, with respect to any Person, any U.S. or non-U.S.
federal, national, state, provincial, local, municipal, international,
multinational or other law (including common law), constitution, statute, code,
ordinance, rule, regulation or treaty applicable to such Person.

            "Lien" means any mortgage, pledge, security interest, encumbrance,
lien or charge of any kind, including, without limitation, any conditional sale
or other title retention agreement, any lease in the nature thereof and the
filing of or agreement to give any financing statement under the Uniform
Commercial Code of any jurisdiction and including any lien or charge arising by
Law.

            "Material Adverse Effect" means, when used with respect to the
Company or any Subsidiary, as the case may be, any change, effect or
circumstance which, individually or in the aggregate, would reasonably be
expected to (a) have a material adverse effect on the business, assets,
financial condition or results of operations of the Company or its Subsidiaries,
as the case may be, in each case taken as a whole or (b) materially impair the
ability of the Company or its Subsidiaries, as the case may be, to perform their
obligations under this Agreement, excluding any change, effect or circumstance
resulting from (i) the announcement, pendency or consummation of the
transactions contemplated by this Agreement, (ii) changes in the United States
securities markets generally, or (iii) changes in general economic, currency
exchange rate, political or regulatory conditions in industries in which the
Company or its Subsidiaries, as the case may be, operate.

            "Material Subsidiary Contract" means any and all agreements,
contracts, arrangements, leases, commitments or otherwise, of the Company and
its Subsidiaries, of the type and nature that the Company is required to file
with the Commission. "Order" means any award, decision, injunction, judgment,
order, ruling, subpoena, or verdict entered, issued, made, or rendered by any
Governmental Authority.

            "Market Value" shall have the meaning assigned to that term in
Section 7.03.

            "NASD" means the National Association of Securities Dealers, Inc.

            "Person" or "person" means an individual, corporation, partnership,
joint venture, trust, university, or unincorporated organization, or a
government, or any agency or political subdivision thereof.

            "Proceeding" means any action, arbitration, audit, hearing,
investigation, litigation, or suit (whether civil, criminal, administrative or
investigative) commenced, brought, conducted, or heard by or before, or
otherwise involving, any Governmental Authority.

            "Regulation S" means Regulation S promulgated under the Securities
Act, as the same may be amended from time to time, or any similar rule or
regulation hereafter adopted by the Commission.

            "Securities Act" means the Securities Act of 1933, as amended, or
any similar federal statute, and the rules and regulations of the Commission (or
of any other federal agency then administering the Securities Act) thereunder,
all as the same shall be in effect at the time.

                                       21
<PAGE>

            "Subsidiary" or "Subsidiaries" means GCI Caymans, Tianhu
International Holding Limited, General Components Limited (Hong Kong) and
General Components, Inc. (New Jersey).

            "Survival Period" shall have the meaning assigned to that term in
Section 7.01.

            "Taxes" means all foreign, federal, state or local taxes, charges,
fees, levies, imposts, duties and other assessments, as applicable, including,
but not limited to, any income, alternative minimum or add-on, estimated, gross
income, gross receipts, sales, use, transfer, transactions, intangibles, ad
valorem, value-added, franchise, registration, title, license, capital, paid-up
capital, profits, withholding, payroll, employment, unemployment, excise,
severance, stamp, occupation, premium, real property, recording, personal
property, federal highway use, commercial rent, environmental (including, but
not limited to, taxes under Section 59A of the Code) or windfall profit tax,
custom, duty or other tax, governmental fee or other like assessment or charge
of any kind whatsoever, together with any interest, penalties or additions to
tax with respect to any of the foregoing; and "Tax" means any of the foregoing
Taxes.

            "Tax Return" means any return, declaration, report, claim for refund
or credit, information return, statement or other similar document filed with
any Governmental Authority with respect to Taxes, including any schedule or
attachment thereto, and including any amendment thereof.

            "Transaction Documents" means, collectively, this Agreement and all
agreements, instruments and other documents to be executed and delivered in
connection with the transactions contemplated by this Agreement.

            "U.S." means the United States of America.

            "U.S. Person" has the meaning set forth in Regulation S.

      8.02 Accounting Terms. All accounting terms not specifically defined
herein or in any of the Transaction Documents shall be construed in accordance
with generally accepted accounting principles as applied in the United States of
America ("GAAP") consistently applied, and all financial data submitted pursuant
to this Agreement shall be prepared in accordance with such principles.

                                   ARTICLE IX

                                  MISCELLANEOUS

      9.01 No Waiver: Cumulative Remedies. No failure or delay on the part of
any party to this Agreement in exercising any right, power or remedy hereunder
shall operate as a waiver thereof; nor shall any single or partial exercise of
any such right, power or remedy preclude any other or further exercise thereof
or the exercise of any other right, power or remedy hereunder. The remedies
herein provided are cumulative and not exclusive of any remedies provided by
law.

      9.02 Amendments. Waivers and Consents. Any provision in the Agreement to
the contrary notwithstanding, and except as hereinafter provided, changes in,
termination or amendments of or additions to this Agreement may be made, and
compliance with any covenant or provision set forth herein may be omitted or
waived, if the Company (i) shall obtain consent thereto in writing from the
holder or holders of at least a majority in interest of the Shares and (ii)
shall deliver copies of such consent in writing to any holders who did not
execute such consent; provided that no consents shall be effective to reduce the
percentage in interest of the Shares the consent of the holders of which is
required under this Section 9.02. Any waiver or consent may be given subject to
satisfaction of conditions stated therein and any waiver or consent shall be
effective only in the specific instance and for the specific purpose for which
given.

      9.03 Notices. All notices, consents, waivers, and other communications
under this Agreement must be in writing and will be deemed to have been duly
given when (a) delivered by hand (with written confirmation of receipt), (b)
sent by telecopier (with written confirmation of receipt), or (c) when received
by the addressee, if sent by a nationally recognized overnight delivery service
(receipt requested), in each case to the appropriate addresses and telecopier
numbers set forth below (or to such other addresses and telecopier numbers as a
party may designate by written notice to the other parties):

If to the Company:                       with a copy to:
General Components, Inc..                Loeb & Loeb LLP
Suite 2021, 20/F, TwoPacific Place       345 Park Avenue
88 Queensway, Hong Kong                  New York, NY 10154

Attention:  Mr. Simon Mu, President      Attention:  Mitchell S. Nussbaum, Esq.
Telephone No.:  852-2167 8298            Telephone No.:212-407-4000
                                         Facsimile No.:  212-407-4990

If to the Purchaser:                     with a copy to:
Huntleigh Investment Fund Limited        KMZ Rosenman
c/o Zetland Administration Limited,      575 Madison Avenue
13/F Silver Fortune                      New York, New York  10022
Plaza, 1 Wellington Street, Hong Kong    Attention:  Paul J. Pollock, Esq.
                                         Telephone No.:  212-940-8555
                                         Facsimile No.: 212-894-5511

      9.04 Costs, Expenses and Taxes. The Company shall pay $17,000 for fees and
disbursements of counsel to the Purchaser incurred in connection with the
negotiation, drafting and completion of the Transaction Documents and all
related matters and transactions. The Company shall pay any and all stamp, or
other similar taxes payable or determined to be payable in connection with the
execution and delivery of this Agreement, the issuance of any securities and the
other instruments and documents to be delivered hereunder or thereunder, and
agrees to save the Purchaser harmless from and against any and all liabilities
with respect to or resulting from any delay in paying or omission to pay such
taxes.

                                       22
<PAGE>

      9.05 Effectiveness: Binding Effect: Assignment. This Agreement shall be
binding upon and inure to the benefit of the Company, the Purchaser and the
respective successors and assigns; provided, that, the Company may not assign
any of its rights or obligations under this Agreement without the prior written
consent of the Purchaser. The Purchaser may assign all or any part of its rights
and obligations hereunder to any person who acquires any Shares owned by the
Purchaser. Any such assignment shall operate to release the Purchaser from its
liabilities and obligations under this Agreement with respect to the Shares, as
applicable, so sold or assigned. A person to whom all or a part of the
Purchaser's rights are so assigned, whether by Purchaser or by a subsequent
person, may, if so agreed to by the Purchaser, become a party to this Agreement,
entitled to those rights and benefits set forth herein applicable to the
Purchaser or such Shares. The foregoing is in addition to, and not in limitation
of; all other rights, powers and privileges of the Purchaser.

      9.06 Survival of Representations and Warranties. All representations and
warranties made in the Transaction Documents, the Shares, or any other
instrument or document delivered in connection herewith or therewith, shall
survive the execution and delivery hereof or thereof.

      9.07 Prior Agreements. The Transaction Documents executed and delivered in
connection herewith constitute the entire agreement between the parties and
supersede any prior understandings or agreements concerning the subject matter
hereof.

      9.08 Severability. The provisions of the Transaction Documents are
severable and, in the event that any court of competent jurisdiction shall
determine that any one or more of the provisions or part of a provision
contained therein shall, for any reason, be held to be invalid, illegal or
unenforceable in any respect, such invalidity, illegality or unenforceability
shall not affect any other provision or part of a provision of such Transaction
Document and the terms of the Shares shall be reformed and construed as if such
invalid or illegal or unenforceable provision, or part of a provision, had never
been contained herein, and such provisions or part reformed so that it would be
valid, legal and enforceable to the maximum extent possible.

      9.09 Governing Law. This Agreement shall be governed by, and construed in
accordance with, the internal laws of the State of New York, and without giving
effect to choice of laws provisions.

      9.10 Headings. Article, section and subsection headings in this Agreement
are included herein for convenience of reference only and shall not constitute a
part of this Agreement for any other purpose.

      9.11 Counterparts. This Agreement may be executed in any number of
counterparts, all of which taken together shall constitute one and the same
instrument, and any of the parties hereto may execute this Agreement by signing
any such counterpart.

                                       23
<PAGE>

      9.12 Further Assurances. From and after the date of this Agreement, upon
the request of the Purchaser or the Company, the Company and the Purchaser shall
execute and deliver such instruments, documents and other writings as may be
reasonably necessary or desirable to confirm and carry out and to effectuate
fully the intent and purposes of the Transaction Documents and the Shares.

      9.13 Transfer. Nothing in the Transaction Documents or the Shares shall
restrict the right and ability of the Purchaser or its Affiliates to transfer,
and the Purchaser is hereby granted the right to transfer any rights, power or
privileges of or under the Transaction Documents or the Shares to its
Affiliates. The foregoing is in addition to, and not in limitation of; all other
rights, powers and privileges of the Purchaser.

                                       24
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have caused this Stock Purchase
Agreement to be executed as of the date first above written.

                              GENERAL COMPONENTS, INC.

                              By:
                                        ----------------------------------------
                                    Name:
                                    Title:

                              HUNTLEIGH INVESTMENT FUND LIMITED

                              By:
                                        ----------------------------------------
                                    Name:
                                    Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}]]